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ABSTRACT
o
Rouesettus aegyptiacus, the fruit bat is a crepuscular frugivore with no obvious access
to either exogenous or endogenous sources of vitamin D. Therefore this animal's
vitamin D status and endocrine system was investigated.
Both captive and wild populations of fruit bats appear to be naturally in a vitamin D
impoverished state. The serum concentration of the principle circulatory, metabolite
[25(OH)D] is undetectable « 4 ng/ml), Fruit bats possess the full compliment of
enzymes associated with the vitamin D endocrine system. This was shown when
labelled more polar metabolites were produced after the administration of 3H vitamin
D3 and 3H 2S(OH)D3' Furthermore, a specific vitamin D binding protein (DBP) is
present. After partial purification, it was revealed that this molecule is slightly larger
in molecular mass than that of humans and baboons.
Thp, intraperitoneal administration of 25(OH)D3 revealed enhanced Io-hydroxylase
activity such that 1.7 times more 1,25(OH)2Ds was produced than 24,25(OH)2D3' The
ratio of these di-hydroxylated metabolites conform with the ratio of these 2 metabolites
in states of vitamin D deficiency and thus confirm the impoverished vitamin D status.
Undetectable serum concentrations of 25(OH)D3 might therefore be explained by a
limited exogenous vitamin D substrate (rotting fruit peels and fungi). Given the elevated
la hydroxylase activity I the small amount'S of 25(OH)D produced would be rapidly
converted to the ....tive metabolite. The low concentration of active hormone appear
adequate for the maintenance of mineral homeostasis as indicated by tightly controlled
serum calcium (2.26 ± 0.17 mrnol/l), magnesium 01.16 + 0.24 mmol/l) and inorganic
phosphorus (2.93 ± 1.01 mmol/I).
Both vitamin D2 and vitamin D3 metabolites were detected in bat serum albeit in very
small amounts, suggesting that fruit bats exploit both exogenous plant sources (skins
of fruit - vitamin 1)2; fungi - vitamin D:3)and might indeed receive some U.V. light
during their crepuscular forays to endogenously produce small amounts of vitamin D3•
In conclusion, fruit bats appear to belong to a small group of animals that naturally
have limited access to Vitamin D, yet the vitamin D endocrine system in these animals
is no different to that of other mammals. These animals have adapted their vitamin D
endocrine system to function well at the low hormone concentrations and they exhibit
no pathological problems associated with relative vitamin D depletion.
i "~
~
1i
DECLARATION
I declare that this dissertation is my own, unaided work. It is being submitted for the
degree of Master of Science in Faculty of Medicine at the University of the
Witwatersrand, Johannesburg. It has not been submitted before for any degree or
..... ~ Date: . ..1.1:(1.1../.1.1" .
\)
iI
examination in this or any other university .
... i4~~ay of {g.ce." ,..J;:f;,C 19.ffJ.
..~.~:k"D.~ ..
(MBROPI CAVALEROS)
(pROF. I.M. PETTIFOR)
(signature of supervisor)
I certify that the studies contained in this dissertation have the approval of the Animal
Ethics Committee of the University of the Witwatersrand (ABC Number 88/189/4).
........J~.-:,:;.(9..o.~.. Date: ... !.t.j;-:..rK-::.J?v
(signature of student)
l!
II
1
iTABLE OF CONTEl\TTS
1.1 Introduction.
1.2 Historical.
1.3 Sources of vitamin D.
1.4 Transport of vitamin D and its metabolites in circulation.
1.5 Vitamin D metabolism.
1.5.1 25-Hydroxylation of vitamin D in the liver.
1.5.2 Hydroxylation of 25 hrdroxyvitamin D3 in the kidney.
1,6 Regulation of vitamin D metabolism.
1.7 Actions of 1,25 dihydroxyvitamin D3•
1.8 Vitamin. D metabolism in animals.
1.9 Fruit bat biology.
2
CHAPTER 1
The biology of Vitamin D and fruit bats; a literary perspective
Page
3
4
8
10
11
12
14
16
17
22
ii
CHAPTER 2
The care and housing of fruit bats.
2.2.1.1.2
2.2.2 Wild caught bats.
2.2.3 Collection of blood samples.
2.2.4 Measurement of serum. calcium, inorganic phosphorus,
magnesium and alkaline phosphatase.
Vitamin .u supplemented bats.
Page
30
30
30
31
32
33
34
34
2.1 Introduction.
2.2 Methods.
2.2.1 Housing and the care of experimental aidmals.
35
2.2.1.1 Captive animals.
2.2.1.1.1 Vitamin D depeleted bats.
iii
CHAPTER 3
Serum concentrations of vitamin D metabolites in the fruit bats.
Page
3.1 Methodology. 37
3.1.1 Competitive protein binding assays to measure serum levels of
25 hydroxyvitarnin D and 1,25 dihydroxyvitamin D. 37
3.1.1.1 Extraction and chromatography of serum samples. 37
3.1.1.2 The rat kidney receptor assay for the measurement
of serum 25 hydroxyvitamin D concentrations. 42
3.1.1.3 The calf thymus receptor assay for the measurement
of serum 1,25 dihydroxyvitamin D concentrations, 50
3.2 Results. 55
3.2.1 Validation of the 25 hydroxyvitamin D and 1,25
dihydroxyvitamin D assays. 55
3.2.1.1 25 hydroxyvitamin assay. 55
3.2.1.2 1,25 dihydroxyvitamin D assay, :58
3.2.2 Results of vitamin D metabolites in the fruit bat serum samples. 59
3.2.2.1 Concentration of 25 hydroxyvitamin D in bat serum. 59
3.2.2.2 Concentration of 1,25 dihydroxyvitamin D in bat
serum. 59
3.2.3 Serum mineral and alkaline phosphatase concentration. 60
~... ; "
3.3 Discussion.
3.3.1 VitaminD status.
iv
Page
G1
61
65
66
68
3.3.1.1 Captive population of bats.
3..3.2 Mineral concentrations.
3.4 Conclusion.
CHAPI'ER4
v
The metabolism of tritium labelled Vitamin D3 and trltlum labelled 25
hydroxyvitamin D3 in the fruit bat.
4.1 Introduction.
4.2 Methods.
~.2.1 Tissue sample collection.
4.2,2 The extraction and chromatography of the lipid samples.
4.2.2.1 Extraction of serum.
4.2.2.2 Extraction of bat kidney homogenate.
4.2.3 Chromatography of vitamin D metabolites.
4.2.3.1 Chromatography through Bio-Sil HA silicic acid.
4.2.3.1.1 Calibration of Bio-Sil HA silicic
acid chromatography column.
LH-20 sephadex column chromatography.4.2.3.2
4.2.4 High pressure liquid chromatography systems.
4.2.5 Methods of the in vivo rIll-Vitamin D3 metabolism study.
4.2.6 Methods used in the in vivo [3H]-25 hydroxyvitamin D3 study.
4.3
Page
71
71
71
72
72
72
73
73
73
79
79
85
86
Results. 87
4.3.1 Results of the in vivo rHJ-Vitamin D3 metabolism study. 87
4.3.2 Results of the in vivo rH]-25 hydroxyvitamin D3 metabolism study. 91
Discussion. 944.4
4.5 Conclusion. 97
vi
CHAPTERS
The productlon of 1,25 dihydroxyvitamin D by the bat kidney (in vitro).
Page
5.1 Introduction. 99
5.2 Methods. 99
5.2.1 In vitro Ice-hydroxylase studies. 99
5.3 Results. 107
5.3.1 Kidney Io-hydroxylase in vitro studies. 107
5.4 Discussion. 113
5.5 Conclusion. 114
CHAPTER 6
The purification of vitamin D binding protein (DBP) from the fruit bat.
6.1 Introduction.
6.2 Methods used in the immunodiffusion studies.
6.2.1 Ouchterlony immunodiffusion.
6.2.2 Radial immunodiffusion (RlD).
6.2.3 Identification techniques to determine DBP activity.
6.2,3.1 r~H]-25hydroxy vitamin D3 binding studies.
6.2.3.2 Albumin determination.
6.2.3.3 Total protein estimation.
6.2.4 Purification of DBP from serum using affigel blue
chromatography.
6.2.5 Ion exchange chromatography.
6.2.6 SDS Polycrylamide gel electrophoresis (SDS-PAGE).
6.2.7 Immunoblotting: western blot analysis.
6.3 Results of the purification of vitamin D binding protein.
6.3.1 Ouchterlony immunodiffusion of five different serum sampn..~.
6.3.2 Results of the purification of baboon DBP.
6.3.3 Purification of fruit bat DBP.
6.3.3.1 Affigel chromatography of bat serum.
vii
Page
116
117
117
118
121
121
122
122
123
124
125
126
127
127
128
133
133
6.3.3.2
6.:3.3.3
6.4 Discussion.
6.5 Conclusion.
jf
viii
Identification of the bat DBP after DEAE
sephacel chromatography using immunodiffusion. 142
Bat DBP identification by western blot. 147
147
149
CHAPTER 7
The utilisation of vitamin D,2or vitamin D3 by the fruit bat.
7.1 Introduction.
7.2 Methods.
7.2.1 Preparation of the serum samples.
7.3 Results.
7.3.1 Utilisation of vitamin D2 or vitamin D3 by the fruit bat.
7.4 Discussion.
7.5 Conclusion.
Page
151
152
152
155
155
156
158
xCHAPtERS
Vitamin D metabolism in fruit bats: a synopsis.
Page
8.1 Vitamin D status. 160
8.2 Vitamin D endocrine system. 161
8.3 Vitamin D metabolism. 162
8.4 Mineral homeostasis. 164
8.5 Conclusion. 165
Ii
LIST OF ABBREVIATIONS
25 (OH)D - 25 hydroxyvitamin D
24, 25 (OH):zD = 24,25 dihydroxyvitamin D
1,25(OH)zD - 1,25 dihydroxyvitamin D
DBP - vitamin D binding protein
HPLC - High pressure liquid chromotography
3H = Tritium
epm = counts per minute
dpm = disintergrations per minute
Pi - inorganic phosphorus
Ca = calcium
mg = magnesium
mg - microgram
ng - nanogram
pg = picogram
J.tl - microlitre
nrn - nanometers
on - optical density
xii
PUBLICATIONS
Parts of this dissertation have been presented and published in the proceedings of
International Scientific Meetings and Workshops.
1. 8th Annual Scientific Meeting.
American Society for Bone and Mineral Research.
June 21-24 19861 Anaheim, CA.
Meropi Cavaleros, F. Patrick Ross and John M. Pettifor.
The fruit bat maintains 'normal' serum levels of 1,25 dihydroxyvitamin D in the
face of very low levels of 25 hydroxyvitamin D.
2. 2nd Bone and Mineral Metabolic. Congress.
29 September-Z October 1986, Cape Town.
F ,P. Ross and M. Cavaleros.
Partial characterization and purification of a putative bat serum vitamin D
Binding Protein (oral communication presented by M. Cavaleros).
3. 7th Workshop on Vitamin D.
24-27 Apri11988, Rancho Mirage, Ca, USA.
Cavaleros M., Pettifor I.M. and Ross F.P.
Partial purification and properties of vitamin D binding protein in serum of the
fruit bat.
xiii
ACKNOWLEDGEMENTS
I extend my heartfelt thanks to my supervisor, Professor I.M. Pettifor for his time,
assistance and encouragement. Dr R. Buffenstein is sincerely thanked for generously
giving of her time, ideas and assessments.
Thanks to Dr 1. v.d, Westhuizen for so kindly catching the wild bats and to the Animal
Unit of the SAIlY.lR, Johannesburg for housing and care of the fruit bats.
Sincere thanks also to Ms L. Richards for her patience and meticulous typing.
I gratefully acknowledge the financial assistance of the MRC Mineral Metabolism
Research Unit.
Finally I would like to thank my family for their continual support throughout this
study.
xiv
'TABLES
Page
Table 1.
Vitamin D2 and D3 and their metabolites in five species of animals (from Horst
et al., 1981). 19
Table 2.
The number of bats used in the various experiments. 31
Table 3.
Vitamin D metabolites, and other serum variable concentrations in the three
groups of bats. 61
Table 4.
The recovery of tritium counts (cpm) in the sera of 5 bats 24 hours' after
they were injected with a known amount of rH]-vitamin D,. 88
Table 5.
Tritated metabolites (% of total cpm) eluted off the silicic acid column
16h and 48h after intraperitoneal injection of [3H]-25(OH)D3• 92
Table 6.
Metabolites formed after the administration of 25(OH)D3 to fruit bats. 93
FIGURE LEGENDS
Figure l.
Photosynthesis of previtamin D3 (Holick, 1981).
Figure 2.
The distribution of the fruit bat (R. aegyptiacusv in Africa.
Figure 3.
The fn, sat (Rouseuus aegyptiacusy.
Figure 4.
The Silica Sep-pak cartridge was used to separate the vitamin D metabolites
prior to t'ieir measurement in individual receptor binding assays. 25(OH)D
eluted in fractions 2-7 and 1,25(OH)2D eluted in fractions 20N2(1,
Figure S.
A typical UV scan of authentic 25(OH)D3 using dual beam spectrophotometry
over the wavelength range 300-220nm. Maximum absorbance occurs at 264nm
coupled to minimum absorbance at 228nm.
Figure 6.
A typical standard curve used in the measurement of 25(OH)D in bat
serum samples.
xv
Page
6
24
27
40
44
48
Figure 8.
A typical standard curve used to determine the concentration of 1,2S(OHhD
in bat serum. 57
xvi
Page
Figure 7.
A typical UV scan of authentic 1,25(OHhD3 using dual beam
spectrophotometry over the wavelength range 300-220nm. Maximum
absorbance occurs at 264nm coupled to minimum absorbance at 228nm. 53
Figure 9.
The separation of vitarnin D metabolites on Silicic Acid column
chromatography after lipid extraction. The different metabolites were
eluted with varying concentrations (If ether/hexane; 20% (3ml) ,
55% (Srol) and 95% (Sml) followed b:' 5ml50% acetone/ether. 76
Figure 10.
LH 20 Sephadex chromatography separation of vitamin D metabolites
(after lipid extraction) on a 2 x 20cm column eluted with 300 ml of
hexane.cfilorofonnimethanol (9: 1:1). 5ml fractions were collected. 78
xvii
Page
Figure 11.
The HPLC chromatography tracings using 4 solvent systems.
A, hexaneiisopropanokmethanol (90:6:4); C, 3% isopropanol!
dichloromethane; F, 8% isopropanol/hexane; G, 80% rnethanol/Hjf).
The flow rate for all the systems was set at 2 ml/minute. 82
Figure 12.
The results of in vivo em-vitamin D3 metabolism. Serum was
extracted and metabolites separated using high pressure liquid
chromatography with 3 different solvent systems. Fig. (a) shows
the elution with solvent system A; [3H]-vitamin D3 eluted in fractions
5-7, [3H]-25(OH)D3 eluted in fractions 9 & 10. Fig. (b) using solvent
system B; [3H]-25(OH)D3 eluted in fractions 13-16. Fig. (c) using
solvent system E; [3H]-25(OH)D3 eluted in fractions 13-15. 90
Figure 13.
LH-20 Sephadex chromatography of the extract of the kidney homogenate
after incubation with 25(OH)D3' 1% aliquots of each fraction were counted
for tritium. The 13H]-1,25(OH)2D3eluted in fractions 34-50. 101
Figure 14.
HPLC tracings of authentic metabolites as well as the tracings of the putatively
purified 1,25(OH)z]) (as indicated on the graph by white arrows) using the 4
different solvent system A, C, F and G.
Figure 15.
(a) The UV tracing of authentic 1,25(OH)zD3•
(b) The putative 1,25(OH)2D scanned before reverse phase high pressure
liquid chromatography. Note the similarity of the putative 1,25(OHhD
tracing to that of authentic 1,25(OH},tD3'
Figure 16.
The comparison of authentic 1,25(OHhD3 (.) and the putative
1,25(OH)2D (0) obtained from the kidney homogenate incubation in a calf
thymus receptor binding assay.
xviii
Page
103
109
111
oFigure 17.
(a.) The cross reactivity of bat, baboon, chick, rabbit and human sera to
antihuman DBP antibody using the ouchterlony immunodiffusion technique.
The bat and chick sera (wells 2 and 4 respectively) show a spur effect.
(b) Wells 2 and 4 contain human serum, well 3 contains the purified baboon
DBP. The 3 bat pools off the Affigel Blue column are in wells 5,6 and 1
(52~59, 5-10 and 37-51), cross reactivity with human DBP antibody,
occurred inbat pool present in well 6 (fraction 5-10).
(c) Purified bat DBP fractions in wells 1 (37-51), 5 (52-58) and 6 (5-10).
Human and baboon DBP are in wells 2, 3 and 4 respectively. Purified
bat DBP (fraction 5-10) in wells 1, 3 and 5. A blank, human DBP and
baboon DBP are in wells 2, 4 and 6 respectively, and spur effects
between bat and baboon as well as bat and human are evident.
Figure 18.
Affigel Blue column chromatography of baboon serum. A 2.6 x 9cm column
was packed with Affigel Blue and 70 fractions (4ml) were collected. The
fractions were each assessed for total protein at 280nrn ~--~, albumin t--)
and [3H]-2S(OH)D3 binding E-··). 5 peaks; fractions 5-10, 11-36, 37-42, 43-51
and 52-59 were noted,
xix
Page
120
130
xx
Page
Figure 19.
15% SDS-PAGE electrophoresis of the pooled fractions obtained after Affigel
Blue chromatography of baboon serum. Pool 2 (11-36) contained a single
band which was identified as DBP by RID. 132
Figure 20.
Affigel Blue column chromatography of bat serum. 70 fractions (4ml) were
collected and each assessed for totalprotein absorbance at 280 nm H,
ablumnin t-) and [3H]-25(OH)D:3activity E--). '.ine 3 fractions pooled were
5-10, 11-36 and 37-58. 135
Figure 21.
15% SDS-PAGE electrophoresis of the pooled fractions obtained after
Affigel Blue chromatography. The bat DBP eluted in pool I (5-10), 137
Figure 22.
15% SDS-PAGE electrophoresis of human DBP (lane 5) and bat DBP
(lane 9), run against molecular weight standards (lane 2). 139
xxi
Figure 23.
The determination of the relative molecular weights of the bat and
human DBP determinated by SDS-PAGE electrophoresis. Human DBP had a
row of 56340 and bat DBP had a mw of 61 600, using information
extrapolated from (Figure 22). 141
Figure 24.
DEAE-Sephacel chromatography of the partially purified bat DBP. 30 fractions
(lOml) were collected and absorbance of each measured at 280nm. Fractions
were assessed for DBP a....tivity by RID. Immune-cross-reactivity was shown
to be present in fractions 18-21. 144
Figure 25.
Western Immunoblot of the partially purified bat and baboon DBP. 146
Figure 26.
(a) The separation of authentic 1,25(OHhD2 and 1,25(OH)2D3 eluted off
HPLC using the solvent system hexane.methanol.dichloromethane
(85:5:7,5) as measured bv absorbance at 264nm.
(b) Authentic 1,25(OH)zD2 and 1,25(OH)2D3'
(c) human serum to which was added 1,25(OHhD2'
(d) human serum and
(e) bat serum.
The samples (b,c,d and e) Were extracted and chromatographed by HPLC using
the solvent system described in (a) and the eluted fractions (0.5m1) were
measured in the calf thymus receptor assay for 1,25(OHh_D activity. 100%
binding of 3[H]1,25(OH)2D3 is equivalent to zero concentration of the
1,25(OL)2D metabolite.
xxii
Page
154
CHAPTER 1
The biology of Vitamin D and fruit bats: a literary perspective
1
21.1 Introduction
In all mammals studied to date, vitamin D appears essential for life, regulating many
vital biological functions (Kumar, 1980). This fat soluble vitamin plays a major role
in calcium and phosphorus homeostasis. Mineral balance is maintained )y several
processes; including the stimulation of active calcium transport in the intestine, the
control of mineral excretion and the mobilization of minerals from bone. In this ":ly
plasma concentrations of minerals are tightly regulated. In addition vitamin D has
several functions not directly related to mineral homeostasis, these include the
activation of T lymphocytes (Tsoukas et aI., 1984), the ccntrol of peptide hormone
secretion e.g. parathyroid hormone .(pTH) (Norman and Litwack, 1984), prolactin
(Richard et al., 1991), and insulin (Kadowaki and Norman, 1984), and mediates the
development and control of immunity (Haussler et aI., 1988; Haddad, 1984; Manolagas
et aI., 1990).
The vitamin D system is unique amongst hormones in that it is dependent on
environmental factors (e.g. sunlight) for the provision of the parent vitamin and en
multi organ participation in both the activation and biological expression of the active
metabolite (Stumpf, 1988; 1991). The principal circulating metabolite is 25-
hydroxyvitamin D (25(OH)D). This metabolite is further hydroxylated to two more
polar metabolites» either the active hormone, l,25-dihydroxyvitamin D (1,25(OHhD)
or a second metabolite, 24,25-dihydroxyvitamin D (24,25(OH)2D) which is thought to
be inactive. The kidney is the central endocrine gland that produces in regulated
quantities the two key dihydroxyvitamin D metabolites (Norman, 1990).
3The historical background to vitamin D and its function has been extensively reviewed
(Norman et at, 1982; DeLuca, 1984; Kumar, 1986). Most of the early work on
vitamin D examined the effects of vitamin D, or lack thereof, on bone diseases such
as tickets and osteomalacia.
Vitamin D deficiency, as seen in rickets, was well documented from as early as the
17th century (Glisson and Whistler, 1929), however it was the nutritional studies of Sir
Edward Mellanby in 1919 that demonstrated rickets to be a disease resulting from the
deficiency of vitamin D. The work by McCollum in 1922 showed that there was more
than one fat-soluble vitamin and he clearly differentiated between vitamin A and
vitamin D deficiency. This early work thus established the nutritional importance of the
fat-soluble vitamin D.
A most important discovery was that ultraviolet light could correct vitamin D deficiency
(Huldschinsky, 1919; Hess and Gutman, 1922). Steenbock and Black in 1924
demonstrated that vitamin D, either synthesised in vivo in the skin of rats or available
in rat food, was ultimately produced by irradiation with UV light. Shortly thereafter (in
the 1930's) the chemistry of vitamin D was analysed by researchers such as Windaus
et al., 1936 who identified the sterols, vitamin D2 in 1932 and vitamin D3 in 1936,
Since then the field of vitamin D research had advanced in leaps and bounds, both in
respect of the function and the biochemical metabolism of vitamin D.
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41.3 Sources of vitamin D
There are two major sources of vitamin D. In animals it may be endogenously
produced in the skin in the presence of ultraviolet light or it may be acquired by dietary
intake. Vitamin DJ is the form naturally produced in the skin by the action of ultraviolet
light. It may also be acquired from the ingestion of animal products. Vitamin Dz is
formed by the irradiation of the plant sterol (ergosterol) and this form may be ingested
in the diet.
In man, both forms are usually present in the circulation though the concentration of
2S(OH)D3 is generally substantially higher tha1125(OH)Dz' Higher serum concentrations
of vitamin D3 metaboiaes reflect the importance of skin synthesis in the maintenance
of normal vitamin D status (Audran and Kumar, 1985; Horst et el., 1988; Reichel et
al., 1990).
Vitamin D3 is synthesised from 7~d.ehydrocholesterol, which is normally present in skin
(Holick, 1984). When human skin is exposed to high energy ultraviolet photons, with
energies between 290 and 315 nrn, previtamin D3 is formed from its precursor,
provitamin D3 (7~dehydrocholester()1). Previtamin D3 is then thermally rearranged to
form vitamin D3 (Bsvelt et al., 1978; Holick et a1., 1979). This latter process takes
place over a three day period (Figure 1).
{)I\..-_
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Figure 1.
Photosynthesis of previtamin D3 (Holick, 1981).
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7The photolytic conversion of 7-dehydrocholesterol tc vitamin D3 occurs both in the
epidermis and dermis in the ration of 80:20. With increasing age, vitamin D3
production decreases in the epidermis with. the resulting possible decrease in serum
vitamin D3 concentration. Other factors which influence the amount of vitamin D,
produced include the duration and intensity of sun exposure, the wavelength and
amount of ultraviolet light reaching the skin and the degree of skin pigmentation.
Darker skin (increased melanin pigmentation) restricts vitamin D3 production and a
black person requires 20 times longer in the sun than a white person to achieve
equivalent vitamin D3 production (Holick et al., 1987).
Vitamin D3 once synthesised is then transported away from the site of synthesis into the
circulation bound to its specific: carrier protein. (Dueland et al., 1982). Previtamin D3
has a low affinity for this protein and therefore remains behind in the skin.
Vitamin D3 can be obtained by eating animal products (such as muscle and fat) however
this source is usually inadequate to maintain a vitamin D replete state. Historically fish
oils (e.g. cod, herring and sardines) have been acknowledged as an important source
of vitamin D. Meat from all domestic mammals is also considered an importance source
of vitamin D (Audran and Kurnan, 1985).
In countries where adequate {.TVirradiation of the skin cannot be acquired, certain
foods such as margarine or milk, have been fortified in an attempt to maintain an
adequate intake of vitamin D.
8In 1986 Ricardo Boland reported the presence of a vitamin D3 like substance in plants
in certain areas of Argentina and Brazil. It was initially found in the irradiated leaves
only of species belonging to the family of Solanaceae, although recently it has been
recorded in the leaves of a number of other plants including alfalfa (Boland, 1986). It
appears that this form of vitamin D3 can indeed be used by the animals, as animals
ingesting the leaves develop hypercalcaemia.
Ergosterol, a plant sterol, can be converted to vitamin Dz by exposure of UV light. It
is not known whether D2 is an important source of vitamin D in herbivores, but in man,
vitamin Dz generally appears to play a minor role in maintaining an adequate vitamin
D status.
1.4 Transport of vitamin D and its metabolites in circulation
Dietary vitamin D is absorbed from the upper part of the gut in the same way as other
fat soluble compounds (Dueland et al., 1982). It enters into the circulation through the
thoracic duct in the chylomicron fraction of intestinal lymph (Dueland et al., 1982).
Like any other fat-soluble compound, only a small fraction of vitamin D and its
metabolites circulate in the unbound state in plasma. Vitamin D and its metabolites are
bound in the circulation to albumin or alternatively to a specific carrier protein (DBP),
the vitamin D binding protein (Dueland et al., 1982; Smith and Goodman 1971;
Haddad and Birge, 1975).
9The specific DBP (also known as Go-globulin) is a highly polymorphic serum
glycoprotein synthesized by the liver. It is distributed in most tissues ego liver,
proximal gut, kidney, skeletal muscle and in lesser amounts in bone, brain and lung
tissues (Harper et al., 1987). DBP is found inall animals with skeletons eg. great apes,
new world monkeys, mouse, rat, horse, cow and dog (Hay and Watson, 1976 a and b)
and is phylogenetica11ywell conserved (Haddad, 1984; Bidmon and Stumpf, 1991).
Debinding protein has a strong homology with serum albumin and alpha-fetoprotein
(Haddad, 1987), and has a higher molar concentration (5 x 1O-6M) in circulation than
the major circulating metabolite, 25(OH)D (5 x lO"sM).All the vitamin D metabolites
are known to bind DBI> in a ratio of one mole of metabolite/ mole of protein. The
order of affinity of DBP for the sterols is thought to be the following.- 25(OH)D =
24,25(OH)2D = 25,26(OH)2D > 1,25(OHhD > vitamin D, with no distinction
between D2 OrD3 binding in man (Haddad and Cooke, 1989). In the physiological state,
at anyone time less than 5% of the binding sites of human DBP are occupied by
vitamin D sterols. As 25(OH)D has the highest affinity and the greatest molar
concentration of the vitamin D metabolites, it is the predominant form bound to DBP
(Haddad, 1987).
Free metabolites, rather than those bound, are active in vivo (Bikle et al., 1985). The
high affinity of DBP for the active metabolite is an important factor in determining the
concentration of vitamin D metabolites available for use by the cells.
o
10
Human t.. ~P has a molecular weight of 58 000 d\~iltonswhile in the rat its molecular
weight is slightly smaller at 52 000 daltons (Haddad, 1987). The DBP concentration
in normal human serum samples is 422 ± 27 mg/L (Imawari and Goodman, 1977;
Bouillon et a1., 1991). Human DBP has a half-life of 2.5 days which is significantly
less than the 12 day half-life of 25(OH)D, and is produced at a rate of approximately
10 mg/kg/day. DBP is excreted in the urine after catabolism by proteases (Kumar,
1986).
Low serum levels of DBP occur in premature infants and in patients with liver disease,
and nephrotic syndrome while an increase is seen in· pregnant women and those
receiving oestrogen therapy. The levels of DBP remain normal in a number (II
situations such as vitamin D deficiency, vitamin D intoxication, hyperparathyroidism,
sarcoidosis, and hypophosphataemic rickets. Thus there appears to be no regulation of
DBP by vitamin D or its sterols.
1.5 Vitamin D metabolism
Vitamin D is considered a prohormone in that it has no biological effect and exerts its
actions only after undergoing further metabolism (DeLuca, 1984; Kumar, 1986). To
date, more than 35 metabolites of vitamin D have been identified. The functional
significance of most of these is unknown (Ikekawa, 1987; Henry and Norman, 1990).
The body is able to store vitamin D for relatively long period of time (Heymann, 1937;
Rosenstreich et al., 1971). Body fat is the major storage site, although muscle, skin and
1.5.1 25-Hydroxylation of vitamin D in the liver
11
bone and liver are also important sites of storage (Mawer et al., 1972; Rosenstrich et
al., 1971).
Activation of the prohormone vitamin D requires a series of hydroxylations. The first
of these takes place primarily in the liver, although some hydroxylation may c cur in
other tissues e.g. lung, kidney and intestine (Ichikawa et al., 1983). Vitamin D is
hydroxylated at the C-25 position to 25-hydroxyvitamin D (25(OH)D) (Blunt et al.,
1968) by the 25-hydroxylase enzyme. This enzyme is located in the microsomal and
mitochondrial fractions of hepatocytes (ponchon and DeLuca, 1969). The hepatic 25-
hydroxylase enzyme, a cytochrome P-450, requires NADFH for its action. The reaction
is inhibited by the absence of oxygen and the presence of carbon monoxide. The 25~
hydroxyl oxygen atom is derived from molecular oxygen (Fraser, 1980).
2~-hydroxyvitamin D is the major circulating vitamin D metabolite in blood. It has a
relatively long half-life of about 5 days in humans. In physiological concentrations
25(OH)D is biologically inactive. Its metabolic pathwav- =re unclear, but significant
amounts are excreted in bile (Arnaud et al., 1984). .ion and DeLuca (1969)
showed that in rats [3H]-vitamin D3 was taken up by the liver within 30 minutes of
administration and that there was a dramatic increase in plasma PHl-25(OH)D3 over
the next 2 hours (ponchon and Del.uca, 1969).
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Although there is no evidence that the hydroxylation of vitamin D is controlled by
serum levels of 25(OH)D, hydroxylation of vitamin D may be controlled by the serum
concentration of 1,25(OH)P (Reichel et a1., 1987). Bell et al. (1984), showed that the
ingestion of large amounts of vitamin D3 increased the concentration of 25(OH)D3 but
when 1,25(OH)2D3 and vitamin D3 was administered together, there was no increase
in 25(OH)D3 concentration. Serum calcium both directly and indirectly may also
regulate various steps in vitamin D metabolism.
Clements et al. (1987) demonstrated a reduction in the half-life of 25(OH)D, in rats on
a calcium deficient diet. Furthermore, addition of 1,25(OH)2D to calcium replete rats
produced a similar reduction in 25(OH)D half..life. These studies suggest that
1,25(OH)zD leads to an increase in hepatic catabolism of 25(OH)D and a fall in
circulating 25(OH)D.
1.5.2 Hydroxylation of 25(OH)D3 in the kidney
Further hydroxylation of 25(OH)D3 takes place primarily in the kidney" Two
metabolizing enzymes, either 25(OH)D-10!-hydroxylase or 25(OH)D-24R-l _;oxylase
are involved (Kawashima and Kurokawa, 1983). The activities of both enzymes are
very tightly controlled by ionic and hormonal balance. There is a reciprocal change in
th '! activities of the two enzymes. During hypocalcaemia, hypophosphataemia and low
vitamin D status, 25(OH)D-24-hydroxylase is completely absent (Fraser, 1980) and
after 1,25(OH)2D3 administration, the 24-hydroxylase activity increases (Kawashima
and Kurokawa, 1983).
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Both hydroxylating enzymes require the presence of oxygen for their activity. Oxygen
is incorporated at either the Cl or C24 position on the ~er0steroid molecule. Both
enzymes are cytochrome P-450-dependent rrrono-oxygenases. These enzymes have
similar biochemical properties to typical steroid hydroxylases, present in adrenal
glands, testes and ovaries (Henry and Norman, 1984).
The activity of the Io-hydroxylase is localized to the proximal convoluted and proximal
straight tubules. Parathyroid hormone (PTH) stimulates adenylate cyclase and increases
Ic-hydroxylase activity specifically in the proximal convoluted tubules, while calcitonin
is responsible for its activation in the straight tubules (Zelikovic and Chesney, 1989).
The mechanisms by which alterations in serum inorganic phosphorus concentration
control the let-hydroxylase enzyme are unclear. Although hypocalcaemia stimulates 1a-
hydroxylase activity through its stimulation of PTH secretion, there is evidence that
alterations in serum calcium concentrations directly effect the activity of the la-
hydroxylase enzyme.
The major metabolite formed from 2S(OH)D3 while in a normo-to hypercalcaemic state
is 24,25(OH)2D3 (DeLuca, 1984). The functions of this metabolite are not known,
although it is thought to be inactive in adult man (Boyle et al., 1973; Lam et al., 1973;
Holick, 1984). Production of 24,25(OH)zD3 appears to be a mechanism of regulating
1,25(OH)2D3 and its production I:; stimulated by an increase in the serum concentration
of 1,25(OHhD3' The kidney is the main site of 24,25(OH)2D3 synthesis but it may also
be produced in intestine, keratinocytes, cartilage and bone cell cultures (Knutson and
Del.uea, 1974; Kumar et al., 1978).
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1.6 Reg!11lationof 1,25(OH)illJ production
The metabolite, 1,25~dihydroxyvitamin D, is the active form of vitamin D regulating
many biological activities including gastro intestinal tract (O.1.T.) absorption of
calcium, phosphate and magnesium, as well as the renal reabsorption of these minerals.
Serum levels of 1,25(OH)zD3 are tightly regulated. Production of 1,25(OHhD3 is
controlled primarily by the calcium requirements of the individual. The principal
regulators of 1,25(OH)zD3 p eduction are PTH, 1,25(OH)zD3 itself, and serum calcium
and phosphorus concentrations (Fraser, 1980; Henry and Norman, 1984; Clements,
1987).
Parathyroid hormone (PTH) has both a direct and indirect effect on Ic-hydroxylase
activity (Kronenberg, 1990) .. In its own right, P'olH promotes tubular calcium
reabsorption (Norman and Litwack, 1987) and the excretion of phosphate, which leads
to changes in the serum concentrations of these minerals. Furthermore PTH promotes
mineral mobilization from bone increasing serum calcium concentrations. Changes in
serum mineral concentration in turn may lead to an alteration in 1,25(OH,hD3
production. Besides stimulating Ic-hydroxylase activity, PTH inhibits 24-hydroxylase
activity.
Serum calcium both directly and indirectly regulates Ie-hydroxylasc activity. indirect
regulation occurs in response to hypocalcaemia stimulating PTH release which in turn
promotes 1,25(OH)2D3 synthesis (Car:~nter, 1989), There is also evidence that
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1,25(OH)zD synthesis might be directly stimulated by the effect of low serum calcium
concentrates on the renal tubular cells.
Dietary phosphate intake modulates 1,25(OH)2DS renal production (Tanaka and Del.uca,
1973). Hypophosphataemia directly increases 25(OH)D3-10!-hydroxylase activity by
PTH independent mechanisms. Low phosphorus concentrations increase the production
of l,25(OHhD3 and not the clearance of 1125(OH)zD,3,thereby increasing the absolute
amounts, of the circulating 1,25(OHhD3 (Portale et al., 1984; Pettifor, 1990). Thus a
decline in serum phosphate concentration produces the same effect as an increase in
PTH, although the magnitude of the phosphate related effect is not as great (Norman
and Litwack, 1987). Increases in serum phosphate oppose the actions of PTli.
Phosphate increases 24-hydroxylase activity and decreases that of Io-hydroxylase.
Hyperphosphataemia, through its action on Io-hydroxylase, decreases the amount of
1,25(OH)2D3 being produced, and thus the absorption of intestinal phosphate resulting
in a decrease in serum levels of phosphate.
1,25(OH)2D3 itself, is another modulator of vitamin D metabolism. It decreases 101-
hydroxylase activity and promotes 24-hydroxylase activity. These actions of
1,25(OH)2D3 appear to result from changes in enzyme biosynthesis rather than allosteric
end product inhibition (Norman and Litwack, 1987).
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Other hormones e.g, oestrogen (Tanaka et at, 1976), prolactin (Zofkova et al., 1991),
insulin (Kadowackl and Norman, 1984), growth hormone, and somatomedins (DuSSQ
et at, 1988) stimulate la..hydroxylase, while heavy metals inhibit Io-hydroxylase
activity but it is unlikely that these ate important regulators (Halloran et al., 1986).
1.7 Actions Qf l~
Over the last ten years, 1,25(OH}zD3 has emerged as one of the most important
regulators of cellular functions related to. the maintenance of mineral homeostasis
(Norman, 1990; 'I'soukas et al., 1984), the differentiation of hematopoietic and immune
cells (Manoglesdorf et al., 1984; Reichel et al., 1987) and the modulation of DNA
replication and cell differentiation and proliferation (Haussler et al., 1988).
The steroid hormone, 1,25(OH)2D~his generally considered to. exert its major effects
by mechanisms that parallel classical sex steroid hormones. These mechanisms typically
involve the binding of the hormone to specific intracellular receptors. The vitamin D
receptor (a 48KD protein) has a ubiquitous distribution, found in all vertebrate phylla
and in many invertebrates (Bidmon and Stumpf, 1991). All tissues studied to. date in
,
mammals possess this receptor (Stumpf et at, 1979; Bidmon and Stumpf, 1991;
Minghetti and Norman, 1988). The consequent Interaction of the hormone receptor
target genes (Hanr.Jer et al., 1988; Minghetti and Norman, 1988),
complex with the nucleus thus promotes the expression by protein synthesis of specific
! ",
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Genomic actions are primarily involved in the classical functions of vitamin D and
involve the formation of specific proteins facilitating the desired action (e.g. calcium
binding proteins) (Nemere et al., 1986). In the nucleus, 1,25(OH)2D3 increases
chromatin template activity and DNA dependent RNA polymerase II activity which
increases the synthesis of messenge, RNA, for example, for calcium binding protein
(CaBP).
Vitamin D may also exert its actions through non-genomic means (Nernere et al.,
1986). Non-genomic actions are more rapid (as they do not involve ,protein synthesis)
and are implicated in signal transduction, cell signalling and cell buffering (Reichel et
1.8 Vitamin D metabolism in animal~
al., 1987).
In ail vertebrates studied to date, and also in some invertebrates, vitamin D andlor its
of animals as well as the rate of metabolism of the two vitamin D analogues.
metabolites are present in one form or another (Hay and Watson, 1976 a and b; Horst
et al., 1988; Henry and Norman, 1984; Kobayashi et al., 1991).
In most mammals 25(OH)D3 is the principal circulating form and 1,25(OHhD3 the most
active metabolite. The ratio of vitamin D2/D3 metabolites reflects the habitat and diet
The vitamin D status of a wide spectrum of animals has been examined and
manipulated. In a comprehensive study undertaken by Horst et al. (1981) vitamin D and
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its major metabolites were quantitatively measured in five species of domestic animals.
These results are shown in Table 1. A number of differences were found in the Vitamin
D status of these five farm animals. All five species had detectable levels of vitamin
D3 and its more polar metabolites. Only sheep had detectable levels of vitamin D2
although all other species had the more polar metabolite, 25(OH)D2? present albeit in
much lower concentrations than in sheep. The higher levels of vitamin D2 in sheep
might reflect the higher intake of Dz due to the ingestion of large amounts of UV-
irradiated grass and the relative absence of vitamin D3 formation in the skin due to the
presence of a thick coating of wool.
The most frequently used experimental animal in vitamin D research is the chick. Its
diet can be controlled as soon as the chick has hatched, thus making it easy to deplete
this bird of its vitamin D reserves within a few weeks. Hughes et al. (1977) showed
that the plasma concentrations of 25(OH)D3 in chicks decreased from 14.1 ng/ml at day
1 to undetectable levels within 3 weeks if the chicks were maintained on a vitamin D
deficient diet. Their levels of 25(OH)Dg could be maintained at between 21-35 ng/rnl
and those of 1,25(OH)P3 between 51-75 pglml if a supplement of 1.4 IU/g of diet was
Most animals (Horst et al.., 1981; Hay and Watson, 1977) discriminate against vitamin
D2 in favour of vitamin D3• The rat is however, the exception to the rule in that it
preferentially uses vitamin D2• It appears that this discrimination reflects differential
metabolism of vitamin D. In both pigs and chicks the discrimination is quantitatively
similar, however in the pig the discrimination is at the 25-hydro;~ylase level, whereas
that of the chick occurs before 25(OH)D production (Horst et aI., 1981).
\)
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Table 1
Vitamin D, and D3 and their metabolites in five species of animals
(from Horst et al., 1981)
SPECIES
turkey chicken cow I sheep I pig-
vit D2* nd nd nd 0.52±0.35 nd
(ng/ml)
vit D3 3.4±O.2 2.3±O.3 1.7±0.7 0.6±0.6 10.2±4.1
(ng/rnl)
25(OH)Dz O.S±0.7 1.6±1.5 5.8±1.7 13.9±3.7 O.8±O.3
(ng/ml)
25(OH)D3 18.2±7.9 25.3±3.9 36.9±7.1 12.9±5.3 74.9±21.2
(mg/rnl)
24,25 (OH)zDz** nd nd 0.7±0.2 6.4±1.0 nd
(ng/ml)
24, 25(OH)2D" 1.2±0.1 2.3±0.2 2.6::1.3 4.4±0.7 20.2±10.3
(ng/ml)
25 ,26(OH)zD2** nd nd nd 0.5±O.2 nd
(ng/ml)
25,26(OH)2D3 O.6±0.4 1.1±O.2 2.5±l.O 1.0±O.3 4.1±0.3
(ng/rnl)
25 (OH)Dr*** nd 11.5~O.5 nd nd 2.0±1.226,23-1actone
(ng/ml)
..
1,25(OH)2D 5L8±31.3 21.2±2.1 38.0±10.4 35.9±30.0 60.3±7.2
(pg/ml)
* nd (not detectable) = < 0.2 ng/ml.
** nd ~ < 0.2 ng/ml.
*** nd = < 0.1 ng/m1.
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given. With a 50 fold increase in dietary supplementation, the levels of 2S(OH)D3
increased to 87-100 ng/ml while the 1,25(OH)zD3 remained at similar concentrations
to that obtained with a 1.4 m/g supplement. Similarly, in rats 25(OH)D3 concentration
increased with supraphysiological vitamin D supplementation, but 1,25(OH)2D3 levels
fell significantly as vitamin D supplementation increased from 2 to 1000 IU/g diet.
Similar results have been shown in mole rats (Cryptomys damarensis) (Buffenstein et
al., 1991).
The hooded seal, a mammal which ingests large amounts of fish, showed no evidence
of vitamin D toxicity despite the high vitamin D intake in its diet (Keiver et al., 1988).
In studies using radio-isotopes, the uptake of [3H]-vitaminD3 resulted in an increase in
[3H]-25(OH)D3 and [3H]-24,25(OH)2D3 concentrations with no detectable increase in
[3H]-1,25(OH)2D3' The plasma level of the 1,25(OH)2D3 in the seal was maintained at
a similar level to those of other mammals and showed no increase even after vitamin
D supplernentation. The levels of 24,25(OH)2D3 in both wild and supplemented seals
were similar, but higher (4-33 ng/ml) than those reported in other mammals, and the
metabolism of 25(OH)D3 to 24,25(OH)2D3 was increased. The increase in vitamin D
storage by seals in their Large amounts of blubber seemed to protect these animals
against vitamin D toxicity.
In most vertebrates studied to date? 25-0HD is the major circulating metabolite of
vitamin D and is detectable using radio-receptor assays (Table 1) (Norman et al.,
1982). However recent studies of fish, horses and mole rats have documented that this
generalization does not always hold true (Takeuchi et al., 1991; Kobayashi et al. 1991;
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Buffenstein et al., 1991). In these species, serum concentrations of 25(OH)D are
undetectable yet 1,25(OHhD3 is present. Further studies using telecosts and
I
cartilagenous fish reveal an absence ofDBP and suggest that the active metabolite binds
to other lipoproteins (Takeuchi et al., 1991; Kobayashi et al .• 1991). The lower affinity
binding to lipoproteins might maintain relatively high free metabolite concentrations.
Some invertebrates are also able to metabolise vitamin D3• For instance the land snail
is able to metabolise [3H]-vitamin D3 to more polar metabolites (Weiner et al., 1979).
More recently rH]-25(OH)D3 was shown to undergo metabolism to an even more polar
metabolite in these animals; the functional importance of this metabolite is as yet
unknown.
The mole-rat which lives in a vitamin D free environment on a herbivorous diet,
appears to be naturally deficient in vitamin D, yet metabolises vitamin D3 to 25(OH)D3
and the more polar metabolite, 1,25(OH)2D3 (Buffenstein et al., 1991). This unusual
mammal exhibits measurable levels of 1,25(OH)2D (16.1 ± 1.98 pg/ml) in association
with undetectable levels of 25(OH)D3 « 4 ng/ml). Both mole rats and horses, have
similar patterns of vitamin D metabolites (no 25(OH)D, yet detectable but low ('
1,25(OH)2D3) and are thought to employ vitamin D independent modes of
gastrointestinal mineral absorption.
Fruit bats (Rausettus aegyptiacus) are also thought to have no access to any obvious
source of vitamin D for these animals are nocturnal, flying frugivores. Therefore this
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fascinating mammal's vitamin D status and metabolism in both the absence of D3 and
with D3 supplementation was investigated.
1.9 Fruit bat biology
The Egyptian fruit bat (Rousettus aegyptiacusi, (E. Geoffroy, 1810), derived its name
after first being described from a specimen seen at the pyramids of Gaza in Egypt
(Smithers, 1983). This !..ati~the second largest bat found in Africa and is gregarious,
living m colonies of thousands in caves where it roosts during the day. At night it feeds
on fruit.
These animals are widely distributed through Africa (FIgure 2) from the southern Cape
Province up through the Transvaal of South Africa, along the easter border up to Egypt
and transversally across the central part of the continent (Smithers, 1983). The fruit bat
is also found in parts of Pakistan and some Arab countries.
The adult animal has a mean weight of about 130 g, an approximate length of 15 em
and full flight wing span in the region of 60 em. There is little sexual dimorphism, with
both sexes having similar mass, size and colour. Skin colour can vary from dark brown
to a light grey on their underbodies. Their eyes and ears are rather large tor the body
size and the face hag an almost doglike appearance (Figure 3).
Figure 2
The distribution of the fruit bat (R. aegyptiacus)
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The female bat usually produces only one young after the mating season which occurs
.in early spring (June-September). During this time the males tend to group on their own
and the female and young bats are separate, almost in a nursery fashion. The gestation
period is about 106 days. At birth the young have closed eyes and flat ears, but within
10 days the eyes open and the ears lift up. The young are suckled for approximately
six weeks during which time the mothers are often seen flying with the pup attached
to her underbelly. The young bats will begin to fly at an age of between nine to ten
weeks.
The fruit bat has a well established sense of smell, which is important in its nightly
search for food. The large well developed eyes are more useful when looking for fruit
at close range, This particular bat is the only one which has an echolocation system,
thus allowing it free movement in total r!arlmess. This system is totally different to that
used by other bat species (Smithers, 1983). These animals are agile fast flyers and are
able to negotiate narrow openings between the branches of trees with complete ease.
The fruit bat circles a suitable tree which has fruit on it from which it can feed and
then settles on the branches. It will either use one of its feet to bring the fruit to its
mouth, while hanging with the other or else will hang onto a branch with both its
thumb claws and hold the fruit against the chest with both feet. Wild figs are by far the
most appealing fruit to the bat. As the fruit begins to ripen, squabbles often occur as
groups of bats feed in the same tree. The skins and seeds from the fruit are discarded
and only the soft inner pulp is eaten. This pulp is not exposed to ultraviolet irradiation
and is thus thought not to contain vitamin D2 or vitamin D3 in substantial quantities.
Figm'c 3.
The fruit bat tRousettus aegyptiacus).
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In Southern Africa figs (Ficus capensis, Ficus petensii and Ficus sansibarlcat form the
basis of their diet. These animals also eat the fruit off the Cape ash tree tKebergia
capensis), Saffronwood (Cassine crocea), Bushmans poison (Acokatuhera oppositifolia)
and Mistletoe (Viscum obscarum); soft garden and orchard fruits (e.g, pawpaw and
bananas) are also eaten. Egyptian fruit bats have cheek poucnes in which food can be
temporarily stored and consumed later at their roost.
o
Grooming is done once feeding has been completed. The hair on the chest of the
animals becomes matted with fruit juices and the bat uses the claws on its feet tc comb
out the hairs (Smithers, 1983), while t~~etoes are cleaned thereafter in the mouth.
Being nocturnal and frugivorous, bats have no obvious access to vitamin D. Free living
bats appear to suffer no ill effects attributed to vitamin D3 deficiency, for they thrive
in their chosen habitats.
A number of captive fruit bats used in vitamin B12 research, presented with signs of
clinical vitamin D deficiency I.e, broken wing bones. We were therefore asked to
Investigate whether the animals had evidence of vitamin D deficiency. 111 initial blood
samples which were analysed, 25(OH)D could not be detect J « 4 ng/ml), The
subsequent measurement of 1,25(OHhD in bat serum samples indicated that this
metabolite was present, and the whole question as to the vitamin D status, metabolism
and transport in this fruit eating nocturnal mammal, Rouseuus aegyptiacus was
Investigated further.
CHAPTER 2
The care and housing of fruit bats
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2.1 Introduction
As the fruit bat, Rausettus aegyptiacus, has no apparent source of vitamin D, a number
of experiments were designed to investigate the fruit bat's vitamin D status and to
assess whether 01' not this animal has the ability to metabolise and transport vitamin D.
In this regard, five major experiments were undertaken:
1. The measurement of circulating vitamin D wEtabolites.
2. An assessment of the in vivo conversion of vitamin D to 25(OH)D and
following that the metabolism of 25(OH)D to the active hormone. 1,2S(OHhD.
3. An in vitro study to determine the presence of the 25·· hydroxyvitamin D
Ie-hydroxylase enzyme in the kidney.
4. An investigation to determine whether or not the fruit bat has a specific vitamin
D binding protein (DBP) for the transportation of vitamin D and its metabolites
in blood.
5. An investigation into whether vitamin D2 or D3 is the major form of vitamin D
in bats jn the wild.
2.2 Methods
2.2.1 Housing and the care of experimental animals
A total of 81 bats were used for the various studies. The bats were divided into three
groups.-
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1. vitamin D supplemented animals (n=33),
2, animals fed on a vitamin. D deficient diet (n=38)
3. wild animals studied immediately after capture (n=10)
Table 2: The number of bats used in the various experiments
wild 10 - vitamin D metabolites
(nM10)
22 - vitamin D metabolites
5 - [3H]-vitamin D3 in vivo
Fruit bats vitamin D- 9 - [3H]··25(OH)D3in vivo(n::::38)
2 kidneys-81
7 - vitamin D metabolites
vitamin D+
(n=33) 26 - purification of DBP
2.2.1.1 Captive animals
Captive fruit bats were cared for in the animal unit of the South African Institute for
Medical Research (S.A.I.M.R.) Johannesburg, South Africa.
They were housed in a large room in which the windows had been completely
blackened out. The sole source of light was a single incandescent light bulb which was
switched on only while the animal unit staff entered the room f-orcleaning and feeding
purposes.
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The fruit bats' diet in captivity usually consisted of washed or peeled fruit, such as
bananas, papaya (pawpaw) and apples. Occasionally unpeeled washed oranges were also
fed to the animals. Each bat was allocated 150g of fruit per day and this was either
increased or decreased according to their appetite. The food allocated per bat was mote
than sufficient to meet the animals nutritional requirements. A favourite fruit of these
animals is wild figs which when available were included in their diet. The fruit was
placed into the animals' enclosure daily in the early afternoon.
The water intake of the fruit bat j.s minimal, with the major source of water being from
their intake of fruit. A shallow water trough was supplied at all times in the room even
though it was not always used by the animals.
Bats maintained on both the vitamin D replete and deficient diets were injected with a
vitamin BIZ supplement (0.5 mg cyanocobalamin/lOOg body weight) every 14 days, to
prevent vitamin B1z deficiency resulting from a peeled fruit diet (van der Westhuizen
~al., 1982).
2.2.1.1.1 Vitamin D depleted bats
The bats required for the vitamin D deplete experiments were maintained in a dark
room and fed on a vitamin D deficient diet described above for a minimum of one year
prior to being used in the experiments.
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The vitamin D deficient group were divided into four subgroups:
L animals whose blood was collected to measure vitamin D metabolites (n=22);
2. bats used in the in vivo rHJ-vitamin D3 study (n=5);
21. bats used in the in vivo fH]-25(OH)D3 study (n=:::9);and
4. bats whose kidneys were used. in the in vitro L-hydroxylase study (Table 2)
(n=2).
2.2.1.1.2 Vitamin D su:gplemented bats
The bats required for the vitamin D replete studies were ~""nPemented orally with a
commercially available paediatric multivitamin syrup, P (parke-Davis), which
contained 100 IU vitamin D, 0.25 mg thiamin, 0.1 mg :dboflavin, 0.12 mg vitamin B6,
0.4 mg vitamin A, 0.12 mg niacin and 12.5 mg ascorbic acid per 150 p..e.
The animals in the vitamin D sunplemented group (n=33) were sub-divided into two
further subgroups:
1. to measure circulating vitamin D metabolites (n=7);
2. to purify the vitamin D binding protein (n=26).
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2.2.2 Wild caught bats
The wild bais used in the study were caught on the farm "Haifned Heights" at
Matlapitsi in the Lebowa area, in the North Eastern region of the Transvaal. Nets were
placed across the entrance of the roosting cave and the animals were caught on their
return to the cave just before sunrise. Wild bats (n= 10) were bled from the wing vein
within 6 hours of their capture to determine vitamin D metabolite levels under natural
environmental conditions.
The weights of vitamin D deficient and vitamin D deplete captive fruit bats used in this
study were Similar (Table 3, page 61) (vitamin D supplemented, bats, 121.7g ± 14.1
(n= 17); vitamin D deficient bats, 118.9g ± 16.9 (n=7». Newly caught wild bats had
a greater average weight, 135.6g ± 8.1 (n=10) (Table 3).
2.2.3 Collection of blood samples
Blood samples were collected from the wing vein of animals, by holding the bats down
unanaesthetised and spreading the wing. A maximum or l ml of blood was collected
into a heparinized syringe using a fine gauge needle (no. 25). Cardiac exsanguination
was used to kill the animals, where necessary. As much blood as possible (± 6ml) was
collected. The blood samples Were kept on ice and spun as soon as pr ssible at 3 000
rpm in a Beckman TJ6R for 15 minutes. Plasma was separated from the red blood cells
and transferred into 1\ microfuge storage tube. If the samples were not used immediately
they were stored at ~201)Cuntil required.
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2.2.4 Measurement of serum calcium. inorganic phosphorus. magnesium and alkaline
phosphatase concentrations
Serum calcium, inorganic phosphorus, magnesium and alkaline phosphatase
concentrations were measured by Mr G. Moodley in the MRC Mineral Metabolism
Research Unit, Baragwanath Hospital, Johannesburg. The measurement of calcium and
magnesium were performed by atomic absorption spectrophotometry on a Varian
Techtron 1200, after diluting the samples in a lanthanum chloride solution (1% La).
Inorganic phosphorus concentrations were assayed following the colorimetric methods
described by Hurst (1967) and Kraml (1966) and commercially available from
Technieen (Timepac Inorganic Phosphorus Reagent - Teclmicon No T40-0012). Plasma
alkaline phosphatase was assayed colorimetrically following the method of
Morgenstern, et al. (1965) and commercially available from Technicon (No T40-0009).
A Technicon Auto Analyser was used for these measurements.
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CHAPTER 3
St·!WIl concentrations of vitamin D metabolites in the fruit bat
:!
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3.1 Methodolog;)!
3.1.1 The competitive protein binrling_assays to measure serum levels of 25(OH)D
and 1,25(OH')J2
As serum samples are not suitable for the direct assessment of the vitamin D
metabolites due to the interference of various metabolites in serum, a reliable extraction
and chromatographic procedure was necessary prior to their measurement by
competitive protein binding assays. The methods used were modified from those of
Haddad and Chyu (1971) an1 Reinhardt et al. (1982 and 1984).
3.1.1.1 Extraction and__g_hromatographyof serum samples
The techniques described in section 3.1.1.1 to section 3.1.1.3 were used to purify and
measure the circulating concentrations of 25(OH)D and 1,25(OHhD in serum samples
collected from fruit bats.
In order to assess recovery of vitamin D metabolites during the extraction procedure,
1000 cpm of rH]-25(OH)D3 (3 pg, 160 Ci/mmol, Amersham) in 20 Itl of ethanol and
1000 cpm of rHl-1,25(OH)2D3 (2.5 fg, 170 Ci/mmol) in' 20 Itl ethanol were added to
a 500 1-'1aliquot of serum pipetted into a glass tube. The mixture was vortexed and
allowed to stand at room temperature for 10 minutes.
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The extraction and chromatography techniques used were those of Turnbull et al.
(1982). All the solvents were either HPLC grade or redistilled prior to being used.
Serum proteins were precipitated by the addition of acetonitrile (1 ml) (Riedel-de Haen,
Holpro, South Africa), followed by vigorous vortexing of the tube. This was then
centrifuged in a Beckman TJ6R benchtop centrifuge at 3000 rpm fer 10 minutes to
pellet the precipitated proteins. The supernatant which contained the extracted lipids
plus the vitamin D metabolites was transferred to a tube containing 500 p.l O.4M
K2HP04 (PH 10.4) and vortexed. The mixture was loaded onto a C18 Sep-pak column
(Waters, USA) which had been prewashed with 5 ml of each of the following solvents:
hexane (Holpro), chloroform, methanol and finally distilled water. After loading the
mixture onto the column, it was washed in the following sequence with 5 1i.11water, 3
ml methanol:water (7:3) and 3 ml acetonitrile, the latter fraction containing the eluted
vitamin D meta.boliteswas collected in a separate tube. The acetonitrile was evaporated
off under a steady stream of nitrogen in a waterbath at 37°C, and the inside of the tube
was washed down three times with approximately 0.25 ml hexane so as to concentrate
all the vitamin D metabolites to the bottom of the tube, and the contents evaporated to
dryness.
The vitamin D metabolites were redissolved in 0.25 m14% isopropanol in hexane and
applied to a silica gel Sep-pak cartridge (Waters, USA), which had been prewashed
sequentially with 5 ml of each of the following solvents: methanol, chloroform, hexane
and 4% isopropanol in hexane. The sample tube was washed twice with 0.25 ml 4%
isopropanol in hexane and each wash applied to the column. The 25(OH)D fraction,
which eluted off the column with .10ml 4% isopropanol in hexane (Figure 4) was
Figure 4.
The Silica Sep-pak cartridge w::.'" used to separate the vitamin " metabctites prior to
their measurement in individual receptor binding assays. 25(OH)t> eluted in fractions
2-7 and 1,25(OH)?D eluted in fractions 20-26.
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~'-.'~1Joratedto dryness and concentrated down under nitrogen in a waterbath. 'Ihis
25(OH)D fraction was then stored in 0.5 ml hexane at -20°C until required for use in
the binding assay.
The Sep-pak cartridge was then washed with 8 ml 6% isopropanol in hexane which
eluted the 24,25(OH):P fraction which was discarded. Finally the cartridge was washed
with 10 ml 15% isopropanol in hexane which eluted 1,25(OH)zD (Figure 4). This
fraction was placed in a waterbath at 37°C and the solvent evaporated off under
nitrogen. Finally the metabolite was concentrated as described above and stored in 250
pI hexane at -20°C until required. The two fractions, 25(OH)D and 1,25(OH)zD were
now ready to be quantitatively assayed.
The recovery of 25(OH)D and I,25(OH)zD during the extraction and chromatographic
steps were assessed using authentic (cold) and radiolabelled vitamin D metabolites as
markers. As described above, known amounts of ["H]-25(OH)D3 and eH]-1,25(OH)zD3
were added to normal serum samples, the sera were extracted as described above and
an aliquot of the acetonitrile supernatant assessed for tritium. In separate experiments
authentic 25(OH)D3 and 1,25(OH)2D3were added to serum samples in physiological
concentrations, the recovery of added metabolites were measured by the appropriate
receptor binding assay after extraction and chromatography.
3.1.1.2
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The rat kidney receptor assay for the measurement of semm 25(OH)D
concentrations
The 25(OH)D receptor was prepared and used as described by Haddad and Chyu
(1971). Adult Sprague Dawley rats used for the kidney receptor preparation were
sacrificed by cervical dislocation.
The kidneys were removed immediately ~and were decapsulated and stored whole at -
20°C prior to use. Kidneys (1O-15g) were thawed, minced and homogenized in a
Polytron in 40 ml ice cold 0.05M sodium phosphate buffer (PH 7.4), (Na2HP04,
0.05M/L and NaH2P04, 0.05WL which were mixed in a ratio of 4 parts to 1 part) and
centrifuged at 3 000 rpm for 10 minutes at 4°C. The supernatant was decanted and
kept, while the pellet was re-suspended in another 40 ml sodium phosphate buffer and
centrifuged as above. The two supernatai..s were combined and buffer added to a final
weight (original kidney tissue): volume ratio of 1:10. This mixture was centrifuged at
4°C for 90 minutes at 18 000 rpm (HA-20.1 rotor; J2-21 Beckman ultracentrifuge).
The supernatant was carefully poured through gauze to filter out any lipid and then
lyophilized.
A stock solution of 25(OH)D3 (Upjohn) at a concentration of approximately 1 mg/ml
of ethanol which was stored at -20°C for up to 3 years was diluted 1/100 with ethanol
to an approximate concentration of 10 p.g/ml. The concentration and purity of this
solution was assessed before use by scanning on a Pye Unicam ] 800 dual beam
spectrophotometer (pye Unicam Limited, Cambridge, England), an example of such a
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Figure 5.
A typical UV scan of authentic 25(OH)D3 using dual beam spectrophotometry over the
wavelength range 300-220nm. Maximum absorbance occurs at 264nm coupled to
minimum absorbance at 228nm.
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scan is shown in Figure 5. The purity of the 25(OH)D3was checked by determining the
absorbance ratio at 265 nm/228 nm, which should be 1.8. The concentration was
calculated using the known molar extinction coefficient of 18 500 (DeLuca, 1984).
From this solution of known concentration two working solutions in ethanol were
prepared, the first at a concentration of 10 ng/50 ",1 was serially diluted for use as
standards and the second at 250 ng/50 .ulwas used as a non-specific binding standard.
Ethanol was used as the blank which was included in the curve.
The receptor binding assay was performed in an ice hath at 4°C. By diluting the 10
ng/50 .«1 solution, nine: 25(OH)D3 standards in the concentration range 0-3 ng/50 ",1
were obtained. Two SO ",1 aliquots of each standard were pipetted into polypropylene
test tubes (12 x 75 rnm, Elkay). In addition duplicate aliquots (50 ",1) of the non-
specific binding standard were included.
The 25(OH)D fraction (prepared as described in section 3. L 1.1) (obtained from 500
",1of serum) to be assayed was evaporated to dryness and redissolved in 500 ",1etnanol,
A 300 p.l aliquot was pipetted directly into a counting vial to determine percentage
recovery and 2 x 50 ILlaliquots were pipetted into 12 x 75 mm polypropylene test tubes
(assay tubes). To each assay and standard tube was added 6 000 cpm rHJ-25 (OH)D3
in 50 !hI ethanol and the mixture was vortexed. After a 30 minute pre-incubation, 1 ml
of the reconstituted kidney cytosol receptor was added to all the tubes. The kidney
cytosol receptor was reconstituted to a concentration of 0.2 mg receptor powder per ml
in O.OSM sodium phosphate buffer. The tubes were incubated for a further two hours
on ice.
, ((
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On completion of the two hour incubation 200 p.l of a well mixed charcoal/dextran
solution was added to each tube to separate the bound from free rHJ-25(OH)D3• This
charcoal/dextran solution was prepared in the same phosphate buffer as had been used
in the assay to produce a final concentration of 0.625% charcoal
(Schwartsmann)/0.0625% T60 dextran (Sigma). The tubes were vortexed and allowed
to stand for 18 minutes "~to4°C, prior to centrifugation for 15 minutes at 3 000 rpm in
a refrigerated benchtop centrifuge.
A 500 {'1aliquot of each supernatant (containing the bound fH1-25(OH)Ds was pipetted
into a counting vial and 4.5 ml of scintillant (Aquagel: Cuemlab, South Africa) was
added. The vials were mixed well by shaking and each vial was counted for 5 minutes
'.
u in a Packard Tricarb 3255 beta liquid scintillation counter. Counting efficiency was
determined using an external standard (ABS ratio).
A standard curve was co structed by plotting the percentage binding of the standards
against the concentration of the standards on semi log paper (Figure 6). The percentage
binding of each of the standards was calculated as a percentage of the cpm obtained for
the zero point. The 25(OH)D concentration in the unknown samples was calculated by
reading off the percentage bound on the graph and correcting for the losses occurring
during the extraction and chromatography which Were calculated from the percentage
recovery of the tracer added at the start of the extraction procedure. The percentage
recovery was determined by dividing the cpm obtained in the aliquot at the end of the
extraction procedure by the cpm added at the start of the extraction.
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Figure 6.
A typical standard curve used in the measurement of 25(OH)D in bat serum samples.
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CALCULATIONS:
(cpm of zero point - c)
a,b =
c =
d =
cpm of duplicates of unknown or standard (500 .ul)
cpm of blank
1. Percentage binding of each standard point or unknown sample.
[(a+b) -;.. 2) - c) -;..d) x 100]
= % binding of each sample.
2. Recovery of added counts at the start of the extraction.
(cpm/300 1&1 aliquot x dilution of origili).,alserum vol x 100)
total cpm added to serum sample
- % recovery
3. Final concentration of 25(OH)D (ng/ml)
eng of 25(OH)D off graph x dilution (vol of semm) x 100] -;.. % recovery
1ml
= ng 2S(OH)D/ml serum.
In all the 2S(OH)D assays performed, two control sera were included. OHe was a
pooled serum sample from chicks fed on a laboratory prepared vitamin ndeficient diet.
and kept in a light free environment and the other a serum pool from normal human
subjects. The concentration of 25(OH)D W3.s recorded as ng/ml of serum. The
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validation of these control sera for use in the 25(OH)D assay is discussed in section
3.2.1.
3.1.1.3 The calf thymus receptor assay for the measurement of serum
1,25(OH)1D levels
Thymus glands were removed from young calves between 5-20 weeks old. These were
obtained from the Johannesburg <\.battoir,South Africa. After removing the thymus
gland, it was immediately rinsed in ice cold saline, sliced into small squares, snap
frozen on dry ice and stored at -75°C until processed. An approximately 5g piece of
each gland was thawed and individually processed to assess receptor activity. The tissue
was minced through a stainless steel mincer and homogenized at 25% (w/v) with
buffer, (0.05M Tris, O.5M KCf, 0.OO15MEDTA, 0.OO5MDDT, O.OIM Na2Mo04'
pH 7.4) as described by Reinhardt et al. (1982). The homogenates were centrifuged at
45 000 rpm for 90 minutes using a 6GTi rotor in a Beckman L7-55 high speed
centrifuge. The supernatants were removed, a note made of each volume and the
proteins precipitated by slow addition of ground ammonium sulphate to 35% saturation
(20.9 g/100 ml) with constant stirring. Stirrir.g was continued for a further 30 minutes
after the last of the ammonium sulphate has been added. Five ml aliquots were
centrifuged for 20 minutes at 10 000 rpm. The supernantants were discarded and the
wet pellets stored under nitrogen at -75°C. When used in the assay, the pellet was
reconstituted to 5 ml with distilled water and diluted appropriately in the Tris buffer.
This dilution varied from between 1;4 and 1:7 depending on the batch of thymus used.
A large scale receptor preparation was performed on the remainder of the thymus gland
A stock solution of 1,25(OH)zD3 (Upjohn) in ethanol at an approximate concentration
of 100 p.g/ml, was diluted with ethanol to approximately 10 j.tg/ml. This was scanned
on a UV spectrophotometer from 300 nm to 220 nm (DeLuca, 1984) and the purity
and concentration were determined as described for the 25(OH)D3 standards in section
3.1.1..2. A typical UV scan is shown in Figure 7.
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which showed the highest receptor binding of rH]-l ,25 (OH)2D3 at the zero point of the
standard curve. The processed thymus was stable for up to 3 months when stored as
a frozen pellet (Reinhardt et al., 1982 and 1984).
This standard was diluted to a concentration of 2 000 ng/ml with ethanol and was stable
for 6 months. When required, it was then diluted to a working standard (60 pg/30 p.l)
in 10 ml of ethanol. A non-specific binding standard in 1 eli of ethanol at concentration
900 pg/30 p.lwas also prepared. The 60 pg/30 p.l standard was diluted to produce eight
standards over the range 0-60 pg/30 p.l with ethanol and the non-specific binding
standard included at a concentration of 900 pg/30 p.l to make up a standard curve. Each
point in the curve was performed in duplicate. The standards and samples were kept
in an ice bath at 4°C until the addition of the receptor protein.
The partially purified 1,25(OHhD fractions obtained from the serum samples (500/-11),
after Sep-pak chromatograph" as described in section 3.1.1.1 were evaporated to
dryness and redissolved in 100 p.l ethanol and vortexed. A 30 ttl aliquot of each was
pipetted into a counting vial to assess the percentage recovery during extraction and
chromatography. Two 30 p.l aliquots were pipetted into borosilicate glass test tubes
52
Figure 7.
A typical UV scan of authentic 1,25(OHhD3 using dual beam spectrophotometry over
the wavelength range 300-220nm. Maximum absorbance occurs at 264mn coupled to
minimum absorbance at 228nm.
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(12 x 75 mm (Corning». To each of the test tubes plus those containing the standards,
1 ml of the diluted receptor was added, and incubated for 45 minutes at 25°C in a
shaking waterbath .: After the 45 minute pre-incubation with the receptor, 30 Itl of
[3H]-1,2S(OH)zD3 (6 000 cpm/ 30 J.tlethanol) was added to each of the tubes which
were then incubated in a shaking waterbath for a further 15' minutes. 200 Itl
charcoal/dextran solution was prepared, as described in the 2S(OH)D assay in section
3.1.1.2 and added to each tube to separate the bound from free 1,25(OHhD in this
assay. The tubes were centrifuged at 3 000 rpm for 10 minutes and a 500 Itl aliquot
containing the bound rHJ-l,25(OH)2D3 was taken for counting as described above.
A standard curve (Figure 8) was drawn on 3 cycle log paper, plotting percentage bound
fH]~1,25(OH)2D3 against concentration of standards. The 30 Itl aliquots pipetted into
vials at the start of this assay were used to calculate the recoveries of rH]-1 ,25 (OHhD3
throughout the entire extraction procedure.
CALCULATIONS:
a,b .-
d =
c =
cpm of duplicates of unknown or standard (500 Itl)
cpm of blank
cpm of zero point - c
1. Percentage binding of each standard point or unknown sample.
[(a + b) + 2) - c) + d) x 100]
= % binding of each sample.
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2. Recovery of added counts at the start of the extraction.
(cpm/30 ttl aliquot X dilution 'of original serum vol X 100) -+ total cpm added
to serum sample
= % recovery
3. Final concentration of 1,25(OH)2D (pg/ml.)
[pg 1,25(OH)2D off graph x dilution (vol of selum) used X 100] + % recovery
1m1
= PB 1,25(OH)2D / ml of serum.
3.2 Results
3.2.1 Validation of the 25(OH)D and 1,25(OH).J2 assays
3.2.1.1
A typical 25(OH)D binding curve is shown in Figure 6. With no added 25(OH)D3 (the
zero point of the curve) approximately 20% of the total counts added was bound by the
ligand.
The validation of the competitive protein binding assay was done by assaying the
25(OH)D concentration in 5 ml of (pooled) human serum by UV absorbance after
HPLC chromatography. The 5 ml sample was extracted as described in section 4.2.2.1.
The lipid extract was chromatographed on Sephadex LH-2D (section 4.2.3.2). The
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Figure 8.
A typical standard curve used to determine the concentration of l,25(OH1D in bat
serum.
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pooled 2S(OH)D region was evaporated to dryness, redissolved in 6%
isopropanol/hexane, (solvent system (E) (section 4.2.4» and chromatographed by
HPLC. The absorbance was measured at 264 nm and the values of 25(OH)D calculated
as ng/ml of serum.
The concentration of 25(OH)D in the pooled human serum when measured by HPLC
was 19.4 ng/ml (n=1). This result was similar to the results obtained from the receptor
binding assay (22.5 ± 3.5 ng/ml (i1=9». The accepted reference range for human sera
is 10-40 ng/ml, as measured in this laboratory.
The vitamin D deficient chick serum sample consistently gave high percentage binding
(95-105%) indicating, as expected, very low levels of 25(OH)D, < 4 ng/rnl (n=5).
These levels were indistinguishable from zero on the standard curve and was recorded
as < 0.2 ng/tube or < 4 ng/ml of serum (when 0.5 ml of serum was extracted). The
recovery of [3H]-2S(OH)D3 which was added to each of the sera as a tracer before
extraction, was 76.8 ± 7.9% (n=35).
3.2.1.2 1,25(OH)2D assa~
A typical 1,25(OH)P3 standard curve is shown in Figure 8. Approximately 10% of the
total counts was bound to the receptor at the top of the curve (0 pg/tube),
The mean 1,25(OHhD concentration of vitamin D deficient chick sera value was 13.0
± 4.8 pg/ml (n=12). The values of the numan control was 39.3 ± 12.9 pg/ml (n=7).
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These results were verified by an independent laboratory (R. Horst, Ames, Iowa,
USA). The recovery of [3H]-1,25(OJ,'i~2D3added to the serum samples as a tracer was
61.0 ± 11.4% (n=26).
3.2.2 Results of the assays for vitamin D metabolites in fruit bats serum sample~
3.2.2.1 Concentrations of 25(OH)D in bat serum
Serum samples from 39 fruit bats were assayed to determine their 25(OH)D values. In
all cases, irrespective of time in captivity, the presence or absence of vitamin D3
supplementation, or whether they were samples from wild animals, the bats had
undetectable circulating levels « 4 ng/ml).
To verify this, a known amount of unlabelled 25(OH)A (200 ng) was added to a
pooled bat serum sample (3 ml). When this sample was assayed, the concentration of
25(OH)D was 70 ng/mI, which showed that all the added material was recovered and
very little other 2S(OH)D was present in bat serum.
3.2.2.2 Concentrations of 1,25(OID.,D in bat serum
Wild bats had a mean 1,25(OH)2D concentration of 10 ± 4 pg/ml (n=10) (Table 3).
This was significantly lower (p<0.02) than captive bats receiving a vitamin D
supplement, which had 1,25(OH)2D concentrations of 46 + 37 pg/ml (11=7). The wild
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bats' 1,25(OH)2D levels were significantly higher than those of the bats kept on a
vitamin D deficient diet; 5 ± 6 pglml (n=22) p ::= 0,000002 (Table 3).
3.2.3 Serum mineral and alkaline phosphatase concentratiofls
Mean plasma calcium levels (Tat·o',. 3) were similar (p>O.05) in all three groups,
although the unsupplemented captive bats (D-) tended to have a lower mean value (2.15
+ 0.34 mmol/L) (n=l1) than the other two groups (2.26 ± 0.17 mmollL, (n=lO)
(wild) and 2.30 ± 0.09 mmol/L, (n=7) (D+» and their values had a greater variance
than those of the wild and supplemented captive groups.
Plasma magnesium concentrations were also similar (p>O.05) in all these groups
(Table 3).
Serum inorganic phosphorus (Pi) levels of wild bats were significantly higher than those
of the vitamin D deficient (p=1.47 x 10-4), and vitamin D supplemented. groups
(p=8.19 x 10-5). Vitamin D supplementation had no effect (p=O.32) on Pi
concentrations in the captive groups.
Alkaline phosphatase levels of the vitamin D+ group were higher than those of the
other two groups. Wild animals had significantly lower alkaline phosphatase levels (p=
0.008) (576 ± 130 IU/L) compared to both captive populations.
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Table 3: Vitamin D metabolite and other serum variable
concentrations in the three groups of bats.
wild captive
(n) vit n· (n) vitD+ (n)
weights 13~,.6±8.1 1l8.9±16.9 121.1±14.1
(g.)
1,25(OH)zD 10.±4* (10) 5±6*# (22) 46±37# (7)
(pg/ml)
Calcium 2.26+0.17 (10) 2.15±0.34 (11) 2.30±0.O9 (7)
(mmol/L)
Magnesium 1.16±O.24 (10) 1.09±O.15 (11) 1.19±O.1O (7)
(mmoI/L)
Inorganic 2.93+1.01* (10) 0.95+0.26 (7) 0.81±O.30* (7)
Phosphorus
(mmol/L)
Alkaline 576+130* (10) 783±127 (6) 1032±2i.6* (7)
Phosphatase
(lUlL)
Values with similar superscripts are significantly different from each other.
(One way analysis of Variance)
* = significant (p <0.05)
# = highly significant (p< 0.001)
3.3 Discussion
3.3.1 Vitamin D status
Field observations suggest that fruit bats in the wild are not exposed to sunlight at any
stage either on their departure from the roosting caves after dusk or on their return
before dawn (Smithers, 1983). Freshly caught wild bats were used to the measure their
natural vitamin D status. They were bled within 6 hours of their capture thus giving an
accurate assessment of vitamin D status in the wild (Table 3) for this mammal.
Like all vertebrates studied to date (Kobayashi et al., 1991; Horst et al., 1981;
Takeuchi et al., 1'?91) the active metabolite of vitamin D was present in the serum of
free ranging bats (Table 3). The concentrations of 1,25(OH)2D, although detectable are
lower than the range (60-100 pg/ml) reported for most mammals (Audran and Kumar
1985; Horst et al., 1981; Halloran et al., 1986), and those for adult man (15-50 pg/ml).
In fact, the levels found in the bat are consistent with those found in severe vitamin D
deficiency in other mammals, although apparently normal free living mole rats have
similar hormone concentrations to those found in the bat.
Despite low levels of 1,25(OH)~, serum calcium concentrations are within the normal
range for mammals (Clark et al., 1986). This might indicate that mineral metabolism
in this mammal is independent of 1.25(OHh_D. Several mammals, most notably juvenile
rats (Tanaka et al., 1972; Brommage and Baxter, 1988) and mole rats (Buffenstein and
Yahav, 1991; Buffenstein et al., 1991; Skinner et al., 1991) show a positive mineral
balance, despite low 1,25(OH)2D levels. Furthermore studies of mole rats, suggests that
mineral metabolism is independent of vitamin status (Buffenstein and Yahav, 1991;
Yahav and Buffenstein, in press).
The role of vitamin D in mineral metabolism in the fruit bat has to date not been
studied. However the tendency to lower serum calcium values in the vitamin D depleted
captive bats suggest that small amounts of vitamin D might be necessary to maintain
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normal mineral homeostasis. The' small number of bats in which serum calcium was
measured and the large scatter of the values might explain the lack of statistical
significance in the serum calcium values between the vitamin D replete and vitamin D
deplete animals.
In none of the 39 serum samples measured for vitamin D metabolites was 25(OH)D
detected. That the levels of 25(OH)D were very low « 4 ng/ml), was confirmed by
the measurement of 25(OH)D after the addition of known amounts of unlabelled
25(OH)D3 to bat serum (Section 3.2.2.1). The values obtained were not different from
the amount of 25(OH)D added to the bat serum.
Serum concentrations of 25(OH)D were below the sensitivity of our assay « 4 ng/ml).
Undetectable concentrations of 25(OH)D usually reflect vitamin D deficiency (Audran
and Kumar, 1985). This might indeed be the case, for bats have no obvious source of
the precursor to 25(OH)D. Thus, one would expect to observe the pathological picture
(Audran and Kumar,1985; DeLuca, 1984) of vitamin D deficiency in bats (such
fractures, weakness and deformities), which was not noted in any of the bats (ca}"
or wild) in the present study. As mentioned earlier, it is possible that the bat do
require vitamin D for normal bone and mineral homeostasis.
Alternatively, undetectable plasma 25(OH)D concentrations might reflect a natural
species specific phenomenon. Horses (Horst et al., 1988), mole rats (Buffenstein et aI.,
1988; Buffenstein et a1., 1991) and sharks (Kobayashi, 1991) do not appear to employ
25(OH)D in a similar way to most mammals, as the principal circulating form of
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vitamin D (Norman and Litwack, 1987). It is possible that bats, like these exceptions
to the normal pattern, regulate vitamin D3 metabolism at the level of the active
metabolite (1,25(OH)2D3)' using the inactive 24,25(OH)2D3 as II hormone reservoir,
which could then be further hydroxylated to 1,24,25(OH1D3 in situations of calcium
lack (Kumar, 1984; Henry, 1992).
Another alternative is that vitamin D requirements of the fruit bat may have evolved
into a finely tuned system whereby the metabolism of vitamin D occurs through the
known biochemical pathways (Norman, 1990) to the final active hormone 1,25(OH)2D
but that substrate levels of 25(OH)D re ... Jj the kidney to produce 1,25(OHhD are
very much lower than in other mammals. All the 25(OH)D, available to the animals,
could wen be converted to 1,25(OH)2D. Thus all the vitamin D obtained by the bat, is
utilized in the most efficient way possible. This would be highly adaptive as vitamin
D is not obviously available to this nocturnal fruit eating mammal and perhaps only
small quantities are indeed obtained.
A further possible explanation, could be that 25(OH)D is not transported bound to a
vitamin D binding protein. Rather all 25(OH)D is found free, thus rendering it
available in smaller amounts for the action of hydroxylating enzymes (Fraser, 1980).
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3.3.1.1 Captive Roputation of bats
The housing of the fruit bat in captivity simulated, as closely as possible, this
mammal's environmental conditions in the wild. As the diet was considered to be
vitamin D deficient, a group of animals were supplemented with vitamin D in captivity,
to assess the effect of vitamin D supplementation on vitamin D metabolism and mineral
homeostasis.
Animals not receiving a vitamin D supplement and maintained in captivity for long
periods, showed similar serum mineral values to those of non-captive animals (Table
3), although 1,25(OH)zD levels were lower, and there was a tendency (though not
statistically significant) for serum calcium values to be lower.
Animals -eiving a physiological supplement of vitamin D3, has markedly raised (4
times) 1,25(OH)2D levels compared to wild bats, although 25(OH)D levels still
remained undetectable (Table 3). These data are at variance with vitamin D3
supplementatio j studies of another mammal with no obvious vitamin D source
(Buffenstein et al., 1991). Mole rats in the wild have undetectable levels of 25(Cli)D,
yet when given a vitamin D supplement, 25(OH)D concentrations are elevated to within
the normal range for mammals (Buffenstein et al, 1991). Data obtained from the
vitamin D::;supplementation group in the present study, are thus surprising. It would
be expected if the 25(OH)D substrate was naturally limiting, that when oral ',itamin D3
supplements were given, 25(OH)D3 would become detectable as was the case with the
mole rats. A possible explanation is that the dose of vitamin D was sub-physiological,
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thus preventing the accumulation of 25(OH)D to detectable levels in the animals. All
available 2S(OH)D would then be rapidly converted to more polar metabolites.
Bats ill captivity receiving a vitamin D3 supplement showed significantly higher serum
concentration of 1,25(OH)P3 than those 110\ supplemented, Vitamin D3
supplementation brought the serum 1,25(OH)2D3 concentrations into the same range as
other mammals (Audran and Kumar, 1985; Horst et al., 1981). This implies that bats
in the. wild lack sufficient vitamin D3 substrate and are compelled to maintain the
active metabolite at below normal concentrations. They must therefore have either
adjus:.Ai their mode of mineral homeostasis to function adequately at low 1,25(OHhD3
concentrations or alternatively maintain free 1,25(OH)2D3 levels within the normal
range but with a reduced total 1,25(OH)lD3 concentration.
3.3.2 Mineral concentrations
Irrespective of vitamin D status, captive and wild bats tightly regulated serum calcium
and magnesium levels (Table 3) within the normal range for mammals (Clark et al.,
1986;, Schaamfsma et al., 1988). This indicates the importance of these minerals in
homeostatic functions and the need to tightly regulate them by whatever means. It is
possible that serum concentrations of these minerals are not reg.aated by 1,25(OHhD3'
as supplementation with vitamin D3 did not alter their concentrations. However the
tendency for lower calcium values in the vitamin D deficient captive animals suggests
that the low concentrations of 1,25(OH:h,D are necessary for no-mal calcium
homeostasis.
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Inorganic phospLlonlSlevels in captive animals were much lower than the free ranging
animals. Vitamin D3 supplementation had no influence on these concentrations. We
therefore cannot attribute a decrease in Pi to vitamin D status, nor can Pi concentrations
be the prime regulator of 1,25(OHhD levels. Experimental intervention must be the
cause of the low values in captivity. Low Pi COl centrations might be the main cause of
the broken wing phenomena originally attributed to vitamin D deficiency. A normal
phosphate concentration is essential for life in that it 1S intimately involved in ATP
production and hence energy metabolism (Lehninger, 1975). The bone reservoir ofthis
substance might therefore be drawn upon, to maintain serum Pi and thus result in a
decrease in bone density. This in turn would increase the risk of bone fracture. Despite
this, few bats in our study presented with these symptoms.
It is possible that the lower serum Pi values, might reflect a dietary lack. Although the
diet consisted of mainly peeled fruit, it was ::ot possible to reproduce the wild bats' diet
of mainly wild figs.
Alkaline phosphatase levels were lowest in wild caught animals and were markedly
elevated in captive populations. It is possible that low serum Pi might result in the
elevation of alkaline phosphatase levels through its effect on bone mineralization and
turnover.
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3.4 ConclusioI\
Not one of the serum samples from the 39 bats used for the measurement of 25(OH)D
had detectable levels of 25(OH)D present. Despite this finding, detectable levels of the
active hormone 1,25(OH)2D were present in all the samples assayed. There was a clear
distinction between the concentrations of the 1,25(OHhD levels in the three groups of
bats assessed in these experiments. The levels in the vitamin D deficient group was
significantly lower than those in the other two groups. The data indicate that despite
unmeasurable levels of circulating 25(OH)D, the bat is able to maintain detectable
levels of the 1,25(OH)2D even in the wild state, suggesting that a small but significant
amount of vitamin D is ingested by bats in their natural habitat.
Calcium and magnesium concentrations measured in the bats in the three groups
showed no significant change with vitamin D status (Table 3), indicating that these
minerals were tightly regulated in a manner possibly independent of vitamin D.
Inorganic phosphorus values did not follow the same pattern as those of calcium and
magnesium (Table 3). Wild bats had significantly higher. Pi concentrations than those
held in captivity and this marked difference must be due to captive intervention
treatments unrelated to vitamin D status.
Alkaline phosphatase concentrations in all three groups were high, possibly indicating
a rapid rate of bone turnover. Values in wild bats were lower thar in captive animals.
Although alkaline phosphatase iso-enzymes were not measured it is possible that the
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higher alkaline phosphatase values in .the captive animals reflect the effect of
hypophosphataemia on bone turnover.
Thus wild bats appear to have normal mineral homeostasis despite a lack of an obvious
source of vitamin D. Furthermore the presence of serum 1,25(OHhD concentrations
despite an absence of detectable 2S(OH)D suggests that small amounts of vitamin D are
obtained by these nOr . 'a\ animals. It is possible that this is obtained from the skin of
ingested fruits, wrk. . e been irradiated by sunlight.
Unlike many other mammals that have been studied, circulated 25(OH)D levels do not
provide u good indicator of vitamin D status. The data from the present study suggest
several possible. mechanisms from this finding.-
1. 25(OH)D is nut an intermediate metabolite in the metabolism of vitamin D to
1~25(OH)2D.
2. The fruit bat does not possess a vitamin D binding protein, thus levels of
2S(OH)D are mainly in the free form and are too low to be detected in the
receptor assay used in this study.
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CHAPTER 4
The metabolism of tritium labelled vitamin D3 and tritium labelled 25
hydroxyvitamin D3 in the fruit bat
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4.1 Introduction
Once it had been established that the fruit bat had measurable levels of circulating
1,25(OH)2D but undetectable levels of 25(OH)D, more in depth studies were done to
assess the bat's ability to metabolise vitamin D, and the metab-lic pathways involved.
4.2 Methods
4.2.1 Tissue sample collection
Two experiments were performed to determine vitamin D metabolism in fruit bats. The
first experiment consisted of dosing a number of bats with 3H vitamin D3, while in the
second experiment, different bats were dosed with unlabelled 25(OH)D3 and 3H
25 (OH)D!:, This was done to assess the vitamin D metabolic pathway to the active
hormone, 1,25(OH)iD, in the in vivo situation.
Tissues necessary for the various experiments were dissected from the carcasses of
freshly killed bats. Those which were not required immediately were stored in
aluminium foil or plastic containers at -20°C. The kidneys used in the
25-hydroxyvitamin D Io-hydroxylase experiments were processed as soon as they were
removed from the animals. Blood samples Werecollected as described in section 2.2.3.
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4.2.2 The extraction and chromatography of the lipid samples
The method of extraction of lipids from serum and bat tissue samples obtained for the
different experiments was that developed by Bligh and Dyer (1959),
4.2.2.1 Extraction. of serum
To serum (lml) was added 5.75 ml methanol:chloroform:water (2.3:2.3: 1.15) and the
mixture well mixed. After centriguation for 15 minutes at 3000 rpm, the mixture
separated into three phases. The top aqueous phase was transferred into a second tube,
so that it would not interfere with access through the protein interface to the lower lipid
containing chloroform phase. The chloroform lipid layer was transferred into a third
test tube and evaporated to dryness under a stream of nitrogen at 37°C. The aqueous
phase and the protein layer were re-extracted with chloroform (0.8 ml), and after
centrifugation the two lipid extracts were combined and evaporated to dryness. The
lipid extracts were then redissolved in 0.5 ml hexane and stored at -20°C until
chromatographed.
4.2.2.2 Extraction of the bat lddney homogenate
Extraction of lipids from bat kidney followed the same procedure however in this case
Ig of tissue was used with 3.8 ml of the ethanol: chloroform: water (2:2:1.8) mixture
(Bligh and Dyer, 1959).
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4.2.3 ,Chromatography of vitamin D metabolites
The extracted samples were either chromatographed on Bio-Sil Silicic Acid (Section
4.2.3.1) or LH-20 Sephadex (Section 4.2.3.2) as required. Bio-Sil Silicic Acid was
used to chromatograph serum samples as they contained only small amounts of lipid.
In the case of bat kidney tissue, the amount of lipid present was larger and therefore
these samples required chromatography through a LH-20 Sephadex column.
4.2.3.1 Chromatography through Bio-Sil HA silicic acid
Silicic acid chromatography was used to separate a number of vitamin D metabolites,
as described by Delvin et al. (1985). Prior to use, the Bio-Si1 HA silicic acid powder
(SOg) (Bio-Rad, Richmond, CA) was washed extensively in re-distilled ether (BDH),
the bulk of the ether was then aspirated off and the silicic acid allowed to air dry until
no trace of ether was detected. The silicic acid was then activated at 100°C for 1 hour
in a drying oven. Once the activation was completed, re-distilled hexane (Holpro,
Johannesburg, South Africa) was added immediately to the powder and the slurry stored
in this wet form until required for use.
4.2.3.1.1 Calibration of Bio-Sil HA silicic acid ch.l'Omatography column
The column, a 0.5 x 8 em pasteur pipette stoppered at the lower end with a cotton wool
plug, was packed with a slurry of the silicic acid to a height of 4 cm. The column was
calibrated using [3H]-vitamin D3, [3H]-25(OH)D3 and [3H]-1,25(OH)zD3• Each
il
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metabolite was initially chromatographed separately and finally in combination. Fifty
microlitres of each metabolite containing approximately 1500 epm was pipetted into a
glass tube, the ethanol was evaporated off and 1 ml 20 % ether/hexane added to the
tube. The tube was wen mixed by vortexing and the contents applied onto the column
using a pasteur pipette. The tube was further washed with two consecutive 0.5 ml
washes and each applied to the column as the previous application ran into the silicic
acid. A third m1 of the 20% ether/hexane was applied to the column. The column was
then eluted successively with 5 ml of 55% ether/hexane, 5 ml of 95% ether/hexane and
5 m150% acetone/ether and each fraction collected separately as described by Delvin
et al. (1985). Each of the eluted fractions was evaporated at 37°C under a steam of
nitrogen. Thereafter the contents of each tube were transferred into scintillation
counting vials with several washes of hexane. Scintillation fluid was added to each vial,
which was counted for tritium in a beta liquid scintillation counter (parkard Tricarb
3255).
Following chromatography, the metabolites eluted in the following fractions (Figure 9);
vitamin D in the 55% ether/hexane (3-5 ml), 25(OH)D in the 95% ether/hexane region
(7-9 ml), and the 1,25(OH)2D in the 50% ether/acetone region (11 and 12 ml), The
recovery of each of the three metabolites used, r,H]-vitamin D3, [3H]-25(OH)D3 and
[3H]1,25(OH)2D3-was 60%, 93% and 67% respectively. Other more polar metabolites
would be eluted using 100% methanol (15-18 ml)
75
Figure 9.
The separation of vitamin D metabolites on Silicic Acid column chromate, 1: .•• j after
lipid extraction. The different metabolites were eluted with varying concentrations of
ether/hexane; 20% (3m1), 55% (Sml) and 95% (5ml) followed by 5m1 50%
acetone/ether.
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Figure 10.
LH 20 Sephadex chromatography separation of vitamin D metabolites (after lipid
extraction) on a 2 x 20cm column eluted with 300 ml of hexane: chloroform: methanol
(9:1:1). 5m1 fractions were collected.
5.- ..........
0
4 300 ::l.0 0 r <,-.- .. i EII
E • I L 250 C.L.3 • I UI •C I I I '-v • 0 I• I Cco 0 I
C\I 2 • • t- 200 G• •
+-' • ! I ......ccs • I
:--
ctS
I I
,
150 ho-CD 0 I +.1• q co •n ! Q)c: • 1 UttS 0.4 , a I- 1000 I C..0 I I I 0~ , I ~
0 I
Q I 00.2 • •en . , I r'" 50 E..Q ., ~< , I I :J
0
Is ............ uL
0 ......,_r I I I-
0 40 50 60
Fractions (5ml)
C')
0
N,.-..,
('I') I
0 ('I') 00 .__..c ........ LO._ I C\IE 0 ~ttS 0r-__....._.
LO I> C\J en
~ i I+
79
4.2.3.2 LH-20 sephadex column chromatography
LH-20 Sephadex chromatography as described by Eisman et al. (1976), was used fN'
the separation of vitamin D metabolites in samples containing larger amounts of lipid.
A 2 x 20 cm colum Was packed with a slurry of pre-swollen
(hexane: chloroform: methanol) (9:1:1)LH-20 Sephadex (Bio-Rad, Richmond, CA). The
column was calibrated using authentic vitamin D and 25(OH)D3 and 2 000 cpm of
[3H]-1 ,2S(OH)zD3' The metabolites were premixed in a tube, the ethanol evaporated off
and 1 ml of the eluting solvent added to the tube. The solution was well mixed and with
two 0.5 111.1washes of the same solvent, loaded onto the equilibrated column using a
pasteur pipette. Sixty fractions (5 ml) were collected directly into counting vials. The
solvent was evaporated off, scintillant added and each vial counted in a liquid
scintlllation counter for 5 minutes.
Authentic vitamin D3 and 25(OH)D3 (assessed by absorbance peaks) eluted in fractions
4-10 (20-50 ml) and 11-19 (55-95 ml) respectively, and [3Hl-1,25(OH)2D3 used in the
calibration of this column eluted between fractions 32-49 (160-245 ml) (Figure 10).
A number of different high pressure liquid chromatography (HPLC) solvent systems
were used for the further purification and separation of vitamin D metabolites in the
extracts from tissue and serum samples of the fruit bat.
4.2.4 High pressure liqUid chromatography systems
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Extensive HPLC purification was necessary to separate co-migrating vitamin D
metabolites which might interfere with the determination of the amount of 1,25(OH)aD
produced (Chapter 5).
HPLC was performed either after preparative low pressure chromatography or directly
after extraction if only very small amounts of lipid « 0:5 mg) were present (Section
4.2.2).
All straight phase HPLC was done using a Spherisorb 10 p.m, 250 mm silica column
(Deeside In«, Est. UK.), The pressure pump was a Ll')C Constametric (Milton Roy,
Laboratory Data Control (LDC), Riviera Beach, Florida, USA), coupled to a LDC
1203 UV III monitor with a 245 nm filter and a Vitatron chart recorder,
Reverse phase HPLC was performed using a Zorbax~ODS column attached to the same
pressure pump. The flow rate for all the experiments was 2 mIlmin and 1 ml fractions
were collected. The absorbance sensitivity of the recorder was varied for each of the
experiments.
A number of different isocratic solvent systems were used and .each system was
calibrated using the major vitamin D metabolites.- Vitamin D3, 25(OH)D3,
24, 25(OH)2D3; 1,25(OH)zDz and 1,25(OH)zD3 at a concentration of 100 p.g/20 p.1.
All the solvents used were HPLC grade and supplied by Waters, Millipore, SA. unless
otherwise stated.
c. IJ
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Figure 11.
The HPLC chromatography tracings using 4 solvent systems. A,
hexane.Isopropanohmethanol (90:6:4); C, 3% isopropanol/dichloromethane; F, 8%
isopropanol/hexane; G, 80% methanol/H20. The flow rate for all the systems was set
at 2 ml/rninute.
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The first system (A) was the ternary solvent system described by Jones (1980), using
hexane: isopropanol: methanol in the ratio of 90:6:4(A). Three other systems were also
used. These were binary solvent systems (B,C,D) described by Brown and DeLuca
(1985) making use of varying concentrations of isopropanol/ttichloromethane (nCM)
(B:2%, C;3% and D:4% respectively). The calibration of each of these systems was
performed using the same concentrations of vitamin D metabolites as described in (A).
Thirty fractions (1 ml) were collected.
A further binary solvent system used was isopropanol/hexane at different concentrations
of isopropanol i.e. 6%(E) and 8%(F). The calibration of these two systems was
performed using the vitamin D metabolites described in (A). Forty fractions (1 ml)
were collected.
A reverse phase system was also used, and was equilibrated with 80% methanol/water
(G). The same vitamin D metabolites were used to calibrate the reverse phase column,
and thirty fractions (1 ml) were collected.
The tracings of the four major solvent systems (A, C, F and G) used in the separ...tlcn
of the vitamin D metabolites are shown in Pigure 11. The elution volumes of the
authentic vitamin D metabolites were used to identify the putative metabolites in the
various scmples.
A number of reasons for the use of the different HPLC solvent system are mentioned
in the following paragraphs. The purity of the putative 1,2S(OHhD was increased by
/)
\/
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the elimination of comigrating impurities by using consecutive HPLC solvent systems.
With the elimination of these impurities (possibly other vitamin D metabolites) the
possibility of the binding of other ,i·:.bstancesother than the putative 1,25(OHhD, to the
receptor in the receptor binding assay (Chapter 5) was avoided.
In the experiments in which the bats were injected with the radio-labelled vitamin D
metabolites [3H]-vitamin D3 and rH]-25(OH)D3' it was necessary to obtain good
separation of the injected material from the more polar vitamin D metabolites produced
in vivo hy the bat. The number of counts present in the fractions collected off the
HPLC systems was on occassion small and samples were therefore repurified to ensure
that all the counts present were indeed those produced by the bat and not a
contaminant,
In the experiments performed to try and determine the form of vitamin D utilized by
the bat (i.e. vitamin D2 or vitamin D3) (Chapter 7), it was necessary to obtain baseline
separation of authentic l,2S(OHhD2 and 1,25(OH)2D3 so as to collect each metabolite
separately off the HPLC system which was then included in the receptor binding assay.
With each solvent system used, interfering substances which showed up as absorbance
peaks in the UV tracing were progressively eliminated.
4.2.5 Methods of the in vivo rm-Vitamin D3 metabolism study
Five fruit bats kept in captivity and fed on a vitamin D deficient diet of peeled or
washed fruit for a minimum of one year, were injected intraperitoneally with 1.7 X 1()6
cpm/50 /-tlethanol of [3H]-vitamin D3 (14 Ci/mmol, Amersham). Blood samples (all
were less than 1 ml of blood) were collected from the whig vein of each of the animals
24 hours after the isotope was given. The five blood samples were centrifuged at 3 000
rpm for 15 minutes and the serum separated. The volume of leachwas recorded and a
5 .al fraction taken and counted for total tritium content. The sera were extracted as
described in section 4.2.2, the weights of lipid were noted and the samples prepared
for HPLC.
The first HPLC system used the ternary solvent system (A), described in section 4.2.4.
Each of the five extracted samples was redissolved in 100 .u1of tr '; solvent, 90% was
injected onto the column and the remaining 10% placed 'n a counting vial for
calculation of the percentage recovery after lipid extraction. Of each fraction collected
off the HPLC, 10% was pipetted into vial for calculating the recovery after
chromatography. The fractions containing [3H)-vitamin D3 and [3H]-25(OH)D3 were
separately pooled and concentrated down to dryness. The vitamin D3 pool was
redissolved in hexane and stored at -20°C. The 2S(OH)D3 pool was redissolved in 100
",,12% isopropancl/dichlorornethane for use on the first binary solvent system (B).
Again 10% was taken for counting and the remaining 90% injected' onto the column.
Thirty fractions (1. ml) were collected and 10% of each counted, Fractions which eluted
at the known elution volume for 25(OH)D3 were concentrated dryness, redissolved in
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1001-'1of solvent system (E), the final HPLC system used. As in the previous HPLC
systems, 10% was taken for counting and the remaining 90% injected onto the column.
Forty fractions (1 rnl) were collected directly into vials for counting.
4.2.6 Methods used in vivo [3H]-25(OH)D1 study
Nine vitamin D deplete fruit bats were dlVidedrandomly into three groups of three bats
each. Three solutions containing a fixed amount of [3H]-2S(OH)D3 (5 X 10-5 cpm/50
1-'1 ethanol, 1.5 ng, 160 Ci mmol Amersham) plus different amounts of authentic
25(OH)D2 was prepared. The total amount of unlabelled 25(OH)D3 received by each
bat in the 3 groups was 2, 11 and 21 ng respectively. The 25(OH)D3, dissolved in
ethanol (50 ",1),was injected intraperitoneally as a bolus. At 16 hours a blood sample
was collected from the wing vein of each animal. The samples were centrifuged, the
sera separated and a note made of each volume prior to storage at -20°C. The animals
were sacrificed at 48 hours and as much blood as possible collected by cardiac puncture
from each animal. The blood samples (utlizing l.5 ml serum) were prepared for
chromatography as described in section 4.2.2.l.
Silicic acid chromatography was performed on the serum samples, using a modification
of the method as describe in section 4.2.3.1. The 95% ether/hexane fraction was
eliminated, all the other fractions were assessed for radioactivity and only the 50%
acetone/ether fraction which contained metabolites more polar than vitamin D (eluted
in 55 % either/hexane) was then collected for further processing. The column was
stripped using 5 ml methanol which was collected, evaporated and the tota, fraction
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counted for radioactivity. The latter fraction contained metabolites of vitamin D, more
polar than 1,25(OH)2D.
The 50% acetone/ether fraction was evaporated down to dryness and redissolved in 100
/-,1of the ternary solvent (A), (section 4.2.4). A 10% aliquot was taken for counting
and the remaining 90% was injected onto the HPLC column. Two peaks containing
tritium were identified and each was pooled and evaporated down to dryness and stored
in hexane at -20°C. The second peak (containing the putative 1,25(OH)2D) was
redissolved in 100 p.t of 4% isopropanol/dichloromethane (solvent (D». A 10 ",I aliquot
was counted and the remaining 90 ;.d injected onto the column. Forty fractions (1 ml)
were collected directly into vials for counting.
4.3.1 Results of in vivo [3m-Vitamin D3 metabolism study
The total tritium recovered prior to extraction and chromatography of the sera from the
five bats which were dosed with fH]-vitamin D3 is shown in Table 4.
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Table 4
The recovery of tritium counts (cpm) in the sera of 5 bats 24 hours
after they were injected with known amounts of [3H]~vi.taminD3.
sample vo1. of cpm/5f-tl total cpm/rnl % of total
no. serum serum epm dose admin/ml
serum
1. 452f-tl 137.2 12412 27460 1.61
2. 335/).1 78.0 5226 15600 0.92
3. 585ttl 115.0 13455 23000 1.53
4. 352f-tl 121.3 8540 24251 1.42
5. 46Of-tl 43.0 3956 8600 0.50
would have eluted after fraction 16, but were not detected. In all five samples, the
The results of the HPLC chromatography as described in section 4.2.5 are shown in
Figure 12(a). The [3H]-vitamin D3 eluted in fractions 5-7, while [3H]-25(OH)D3 eluted
in fractions 9 and 10. The more polar metabolites, 24,25(OH)zD3 and 1,25(OHhD3
majority of the counts eluted in the same fractions as authentic vitamin D3 with only
a small number of counts eluting in the 25(OH)D3 fraction. Further metabo., ...m to the
more polar metabolites was not detected in any of these serum sam~les.
system and eluted with solvent B described in section 4.2.4, and shown in Figure 12(b).
The pooled 2S(OH)D3 region offHPLC system A, was injected onto the second HPLC
(13-16). This fraction was analysed on a third solvent system E as described in section
The majority of the counts (60-90%) eluted in the same fractions as authentic 25(OH)D3
4.2.4 and shown in figure 12(c) where only a small portion of the counts did not
co-migrate with authenic material in fractions 13-15.
(\
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Figure 12.
Tale results of in vivo eH]-vitamin Di metabolism. Serum was extracted and
metabolites separated using high pressure liquid chromatography with 3 different
solvent systems. Fig. (a) shows the elution with solvent system A; [3H]-vitamin D3
eluted in fractions 5-7, rH]-25(OH)D3 eluted in fractions 9 & 10. Fig. (b) using solvent
system B; eH]-25(OH)D3 eluted in fractions 13-16. Fig. (c) using solvent system E;
[3H]-25(OH)D3 eluted in fractions 13-15.
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Thus it is clear that the bat is also able to metabolise vitamin D3 to 25-hydroxyvitamin
D3, however because of the small amount of tritiated vitamin D3 converted to 25(OH)D3
it was not possible to determine whether th; bat was able. to further metabolise
25(OH)D3 to the active metabolite 1,25(OH)2D3'
4.3.2 In vivo L'3H] ..25(OH)D3-metabolism stud!l
'.fhe ar
and 48 ho.
bats, at both ,.
'"th~ extracted serum had 10% or less counts present at both If,
.h. '-'Jta1 cpm of the lipid phase of each of the three groups of
~ and at the different stages of the chromatography are
shown in Table 5. Most ~llt~extracted lipid eluted in 1-8 mls using Bio-Sil HA Silicic
Acid, thus eliminating contamination of absorbance peaks on the HPLC sytems used,
The res-tts from tl.e silicic acid chromatography of the 16 hour samples, showed that
only a small number of cpm were present in the 55% ether/hexane fraction (4-8 mls)
containing the majority of lipid and unknown less polar metabolites than 25(OH)D,
except for the groups of bats which received 11ng of 2S(OH)D3 per bat, which had
higher counts (28.7 %). The majority of the counts migrated in the 50% acetone/ether
fraction.
The 16 hour serum samples had more mean total counts present than the 48 hour
samples, although more counts were present in the 50% ether/acetone fraction at 48
hours than at 16 hours. The 100% methanol wash which was used to elute any more
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polar metabolites than the active metabolite 1,25(OH)2D, from the columns, contained
less than 9% of the counts.
Table 5
The tritiated metabolites (% of total epm) eluted off the
silicic acid column after the intrnperitoneally injection
% of total counts in each fraction-
Time Cone Mean Aqueous Etherl Etherl Etherl Methanol
(hrs) 25 (OH)D3 total cpm phase hexane hexane acetone
admin per ml of 20% 55% 50% 100%
ng/bat bat serum
(1~3ml) (4-8ml) (9-13ml) (14-18ml)
2 13041 8.2 5.5 12.4 65.5 8.4
1---
16 11 15458 7.1 5.8 28.7 50.1 8.2
1-----
21 14128 10.1 6.2 16.2 75.8 8.0. -
2 8869 3.9 2.2 5.7 84.7 3.4- 1---.
48 11 11669 3.5 1.5 4.0 86,9 4.1
21 10234 3.3 1.9 7.9 84.5 2.5
'-'
The specific activity of each of the administered doses of 25(OH)D was 9.49 x 10-5
dpm/2 ng, 1.8 x 10-5 dpm/Ll ng and 9.48 x 10-4 dpm/Zlng, The results of HPLC
chromatography of the 50% acetone/ether fracti.ons (Table 6) show that the
concentration of 25(OH)D~ measured in pg/ml, increased significantly from 16 to 48
hours and that this increase was related to the dose of authentic 25(OH)D3 with which
each bat has been injected. The production of the more polar metabolites,
24,25(OH)zD3 and 1,25(OH)zD:lI increased with administered dose of 25(OH)D. In all
situations, the levels of 1,25(OH)~D3produced were greater than those of the 24,25(OH)2D3'
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Table 6
Metabolites formed after the administration of 25(OII)Dj to fruit bats.
I <Blo('d Dose of Metabolites (pg/ml)
Sample . 25 (OH)D3
Collection administered 25(OH)D 24, 25(OH)2D 1,25(OH)2D
Time (ng/bat)
2 27.3 ± 13.2(3.4)* 1.9±1.4 4.3±3.1(2)
16 hrs 11 69,5 ± 63.6(3,5) 9.2±9.5 16.6±12.8
21 53('.9± 190.3{4.5) 22.5 ±9.4(1) 38.6± 11.3(2)
2 24.3±20.2 L1±1.2 2.6±2.7
48 hrs 11 233.4±105.3 5.6±2.2 14.8±9.5
21 444.4±306.0 13.0±8.4 21.9±22.7--
* mean ± SD, n=S in each group.
Values with the same superscript differ significantly from each other.
(1) P ;:::0.05, (2) P = 0.02, (3) P = 0.01, (4) P = 0.00, (5) P = 0.00
The peak regions of both 24,25(OH)2Da and 1,25(OH)2D3 off solvent system A were
re-chromatographed on a second HPLC solvent system D, but insufficient cpm were
present to separate the peaks from baseline and thus the data could not be intepreted.
,
(
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4.4 Discussion
Given the absence of 25 (OH)D in serum of all 39 bats studied, we investigated whether
vitamin D was indeed converted to its more polar metabolites, in a similar manner to
that previously reported in other mammals (Henry, 1992).
The most efficient way of examining the metabolism of vitamin D to its more polar
metabolites uses radioactive tracers (Mawer, 1972). Initially ~H]-vitamin D3 was used
in vivo in five bats on a vitamin D deficient diet. We were able to confirm that the
labelled vitamin D3 was hydroxylated to 25(OH)D;~, for the counts co-migrated with
authentic 25(OH)D3 in all three solvent systems used (Figure 12 a.b.c) using solvent
systems similar to those used by other researchers (Jones, 1,80).
We were unable to document further hydroxylation or metabolism of 25(OH)D in the
24 hour samples as the counts recovered in the serum were too small to detect l o- or
24-hydroxylation.
Thus, in order, to by-pass the 25 hydroxylation step, in the second experiment (section
4.2.6), [3H]25(OH)D" was given intraperitoneally. In this study, we were able to
confirm the further hydroxylation of 25(OH)D3 to the active hormone, 1,25(OH):P3 as
well as to 24,25(OHhD3 (Table 6). The amount of 1,25(OHhD3 produced was directly
proportional to the concentration of 2S(OH)D3 administered (Table 6) at both 16 and
48 hours. This implies that the amount of substrate available for conversion is the
limiting step (Table 6).
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Mean 25(OH)D, 24,25(OH)zD and 1,25(OH)zD concentrations rose progressively with
the dose of 2S(OH)D given, however considerable variation existed in these
concentrations between animals given the same dose. These variations rmght reflect
variable absorption from the intraperitoneal site, different sizes of the animals and
therefore different volumes of distribution, and/or different rates of metabolism.
These data confirm that bats, like all other mammals (Norman et a1., 1982; Del.uca,
1984; Henry and Norman, 1984) possess the complete complement of enzymes for
metabolism of vitamin D to 2S(OH)D and ultimately to the active hormone,
1,25(OH)zD.
That the fruit bat does have the vitamin D metabolite, 1,25(OH)2D, in circulation has
been shown. It is also shown that this animal has the ability to convert vitamin D3 to
its more polar metabolites with the use of tritium labelled vitamin D. The
Io-hydroxylase enzyme must theretore be present and capable of converting exogenous
25(OH)D3 to the active hormone, 1,25{OH)2D3' in the in vivo situation. Thus, in its
natural habitat, the fruit bat must have small quantities of vitamin D in its circulation.
It is of interest to note that after 25(OH)D administration the fruit bat was able to
produce serum concentrations of 1,25(OH)zD, within the range detectable by our radio-
immunoassay (> 10 pg/ml), and not dissimilar from those measured in recently caught
wild bats. The mammal was able to do this at 2S(OH)D concentrations well below the
level of sensitivity of the radio-receptor assay (4 ng/ml). The peak levels of serum
2S(OH)D obtained after 2S(OH)D administration were approximately 0.5 ng/ml.
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These results suggest that the fruit bat probably does have circulating 25(OH)D in its
wild state, but that these levels are too low to be measured by the radio-receptor assay.
24,25(OHhD concentrations rose progressively with the increase in administered of
25(OH)D. In man 24,25(OH)P levels are usually about 10% of the 25(OH)D
concentration (Mawer et al., 1972). Thus values in the ng/ml range are typically found.
The present study indicates that the fruit bat is able to produce 24,25(OH)2D, but the
concentrations obtained are almost 10-: times lower than those found in man. In vitamin
D deficient states, Ic-hydroxylase activity is markedly greater than that of 24
hydroxylase (Henry, 1992). The proportionally lower concentrations of 24,25(OH)zD
(Table 6) after the administration of 25(OH)D3therefore suggest that fruit bats naturally
have an impoverished vitamin D status. In vitamin D replete animals more
24,25(OH)2D should be produced than 1,25(OHhD. Lven at the highest administered
dose of 25(OH)D (21 ng/bat) 1,25(OHhD concentratic was 1.7 times that of
24,2S(OH)2D (Table 6), suggesting that 21 ng/bat is insufficient to alter the vitamin D
status of these animals.
Elevated Io-hydroxylated activity, as indicated by the ratio of 1,2S(OH)zD3 to
24,25(OH)2D3 might lead to the rapid conversion of most of the available 2S(OH)D to
the active metabolite. This could explain the absence of measurable 25(OH)D yet the
presence of 1,25(OH)2D3albeit in lower concentrations than most mammals (Chesney
et al., 1981).
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4.5 Conclusion
Bats do possess the full complement of enzymes necessary to metabolize vitamin D3 to
the more polar metabolites, including the active metabolite, 1,25(OH)2D3'
CHAPTERS
The production of 1,25 dfuydroxyvitamin D by the bat kidney (in vitro)
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5.1 Introduction
o
In mammals 1,25 (OH)zD production occurs in the mitochondria of the proximal tubular
cells in the kidney. Once it had been established that the fruit bat was capable of
metabolising eHl"25(OH)D3 to more polar metabolites, it was appropriate to investigate
the Io-hydroxylase activity of the kidney in an in vitro experiment.
5.2 Methods
5.2.1 In vitro la-hydroxylase studies
Two bats were sacrificed, and the kidneys removed and weighed, following the method
of Henry (1980). The conversion of 2S(OH)D to 1,25(OH)zD by a kidney homogenate
was assessed by the detection of 1,25(OH)zD on HPLC. Several different eluents were
used to separate non ..specific metabolites of 25(OH)D from 1,25(OH)zD.
The kidney tissue was minced and homogenized with a Potter Elvjehlm homogenizer
in 50 ml 0.01SM Tris buffer pH 7.4. The mixture was transferred to a 200 ml conical
flask and preincubated in a shaking waterbath at 37°C for 10 minutes. The reaction
began with the addition of 1.25 mllM sooium succinate, plus 2.5 mg 25(OH)D3 in 50
1-'1ethanol. The incubation was continued in the snaking waterbath for a further 30
minutes. The reaction was stopped with the addition of 100 ml of methanol-chloroform
2: 1. As a marker during the purification of the unlabelled 1.25(OH)2D produced during
q,
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Figure 13.
LH-20 Sephadex chromatography of the extract of the kidney homogenate after
incubation with 25(OH)D3' 1% aliquots of each fraction were counted for tritium. The
[3H]-1,25(OH)2D3 eluted in fractions 34-50.
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Figure 14.
HPLC tracings of authentic metabolites as well as the tracings of the putatively purified
1,25(OH)2D (as. indicated on the graph by white arrows) using the 4 different solvent
system A, C, F uIlj G.
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the reaction, 100000 cpm (300 pg, 170 Ci/mmol) of [3H]-1 ,25(OH)2D3 in 50 1'1 ethanol
was added to the flask containing the total mixture once the reaction had been
completed. The extraction was completed by the method of Bligh and Dyer (1959) as
described in section 4.2.2.2.
The extract lipid was chromatographed on Sephadex LH:-20 as described in section
4.2.3.2. Sixty fractions of 5 ml each were collected and a 1% aliquot of each fraction
counted for tritium. The 1,25(OH)2D3 marker allowed for easy identification of the
putative 1,25(OH)2D region, namely fractions 34-50 (Figure 13), The two pools
[fractions 1-32 (known 25(OH)D) and 34-50 (putative 1,25(OH)2D)] were coJJected and
evaporated down to dryness and the first pool stored in 10 ml hexane at -20ne until
required.
The second fraction containing the putative 1,25(OH)2D was prepared for HPLC by
re-dissolving in 1.00 Itl of the ternary solvent (A) described in section 4.2.4. Forty
fractions of 1 ml were collected, of which 1% was counted, while a simultaneous UV
scan was done at full scale absorbance of 0.128 (Figure 14). The fractions containing
[H3]-1,25(OH)2D3 were pooled and concentrated down to dryness, re-dissolved in 100
f.tl3 % isopropanol/dichloromethane (C), and re-injected onto the HPLC column, using
solvent system C.
Thirty fractions (1 ml) were collected with the UV absorbance scale set to 0.064, and
a 1% aliquot of each fraction was counted. The LH3]-1,25(OHhD3 fractions were pooled
and concentrated down to dryness and re-dissolved in 100 f.tl 8% isopropanol/hexane
I'
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(F) and re-injected onto the HPLC column, using solvent system F. Forty fractions (1
ml) were collected and 1% of each fraction counted. Full scale absorbance of 0,032
was set for the UV monitoring. The [F]-1,25(OH)2Da fractions were pooled and
concentrated.
Prior to the reverse phase HPLC (solvent system G), the pooled putative 1,25(OHhD3
fractions were concentrated down to dryness, re-dissolved in 0.5 ml ethanol and
scanned over the range 300 nm to 220 nm in a Pye-Unican spectrophotometer (DeLuca,
1984). Three authentic 1,25(OH):P3 standards were prepared at concentrations 0.5
p.g/ml, 1.0 ftg/ml and 5.0 f..tg/mlin ethanol, and scanned at the same time as the
putative 1,25(OH)P fraction. The concentration of 1,25(OH)2D was calculated from
the absorbance. The ethanol was evaporated off the scanned material, re-dissolved in
solvent system (G), and the remaining HPLC was performed. The putative
1,25(OH)2D3 fractions off the final HPLC solvent system G were pooled concentrated
to dryness and re-dissolved in 0.5 ml ethanol.
The putative 1,25(OH)2D3 was diluted to a concentration of approximately 20 ng/rnl
ethanol. An aliquot was set aside for receptor binding studies. This "Yasfurther diluted
to two concentrations of approximately 60 pg/30 /-,1and the second to 90t; pg/30 1-'1with
ethanol. The 60 pg/30 1'1solution was diluted to the same concentrations as those of
the standards used to generate the standard curve in the receptor binding assay for the
measurement of 1,2S(OlihD3 in serum samples. The 900 pg/30 1-'1standard was used
undiluted in the curve as a non-specific binding standard. An authentic standard curve
was generated and run in parallel to the putative 1,25(OH)J.D3 curve as described in
107
section 3.1.1.3. Comparative graphs were drawn of the two receptor binding assays as
described by Reichel et al. (1987).
5.3 Results
5.3.1 Kidney I-hydroxylase In vitro Studies
The cpm in each of the resultant fractions off the LH-20 Sephadex column after
chromatography of the extract from the incubated kidney homogenate are show in
Figure 13. The radioactive peak which eluted in fractions 35-47, represents 0.1 % of
the added [3H]-1,25(OH)zD3 counts.
Fractions 35-47 were pooled) concentrated down and injected onto the four consecutive
HPLC solvent systems as shown in Figure : -to
Using solvent system A, a number of absorbance peaks were noted, of which two
eluted in fractions 19-22 and 23-24 and migrated In the region of radiolabelled
1,25(OH)zD3 marker. Unlabelled authentic metabolites 1,25(OH)zD2 and l,25(OH)zD3
eluted in fractions 19-21 and 22-23 respectively when the system was being calibrated.
These fractions containing the [H3]-1,25(OH)2D3 and putation 1,25(OH)zD3 were
pooled, concentrated and injected onto the next solvent system C, which showed fewer
absorbance peaks. Two absorbance peaks (fractions 24-30 and 31-33) eluted and
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Figure 15.
(a) The UV tracing of authentic 1,25(OH)2D3.
(b) The putative 1,25(OH)2D scanned before reverse phase high pressure liquid
chromatography. Note the similarity of the putative 1,25(OHhD tracing to that
of authentic 1,25(OH)zD3•
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Figure 16.
The comparison of authentic 1,25(OH)2D3 (.) and the putative 1,25(OH)2D (0)
obtained from the kidney homogenate incubation in a calf thymus receptor binding
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migrated in the same region as the [W]-l ,25(OH)2D3'During calibration of the system,
unlabelled 1,25(OH)P2 and 1,25(OH)2D3 eluted in fractions 24-26 and 29-33
respectively.
Only a single peak eluted in fractions 18-25. The [H3]-1,25(OH)2D3marker also eluted
in this region. Unlabelled 1,25(OH)zDz and If25(OH)zD3 eluted in fractions 16~20and
21-24 respectively.
Fractions 24-33 off system C were pooled and injected on to solvent system (F). Two
major UV peaks eluted in fractions 2-5 and fractions 28-32. The latter peak co-migrated
with [H3]-1,25(OH)2D. On calibration of system F~ authentic 1,25(OH)zD2 and
1,25(OH)2Dg eluted in fractions 29-32 and 33-35 respectively. Fractions 28-32
containing the [W]-1,25(OH)2D3 from the above system were pooled and
chromatographed on reverse phase HPLC using solvent system (G).
The scan of the putative 1,25(OH)zD3 obtained off the HPLC after the third solvent
system, prior to the reverse phase HPLC was similar to authentic 1,25(OH)zD3 (Figure
15 a and b). In addition the putative l,25(OR)zD showed similar binding characteristics
to the authentic metabolite in the calf thymus receptor binding assay, (Figure 16).
113
Given the absence of detectable 25(OH)D in the serum of fruit bats but the presence
of circulating 1,25(OH1D (Chapter 3) and the fact that bats can convert tritiated
vitamin D3 to the more polar metabolites (Chapter 4), we speculated that the bat has
the renal Io-hydroxylase enzyme necessary to convert 25(OH)D to the active
metabolite, 1,25~OH)2D.
When homogenised renal tissue was given an excess of 25(OH)D3' as described by
Henry (1980), the substrate was converted to putative 1,25(OH)zD, which by several
methods appeared to be 1,25(OH)zD. The substance produced was purified using the
techniques of Jones (1.980). Furthermore the material was found to have a number of
similarities to that of authentic 1,25(OH)zD3(DeLuca, 1984) when scanned over the UV
range 300-220 11m(Figure 15).
We further confirmed that the substance was 1,25(OH)zD3 following the methods of
Reichel et al. (1987). They showed that the receptor binding assay used for measuring
1,25(OH)2D metabolites in serum, was a reliable technique to compare the substance
produced to authentic 1,25(OH)zD3 (Table 6).
These findings therefore confirm that the Io-hydroxylase enzyme was present and
active in the kidney and was able to convert 25(OH)D3 to 1,25(OH)2D3'
-~
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The Io-hydroxylase enzyme has been found in the kidney of frogs (Kobayashi et al.,
1991), reptiles (Takeuchi et a1., 1991; Kobayashi et al., 1991), mammals and birds
(Tanaka et a1., 1976; Norman et al., 1984). Indeed all animals studied to date possess
this enzyme. Although always present in the kidney, this enzyme and thus 1,2S(OH)zD3
production may occur extrarenally (Dusso et al., 1988). The enzyme has been found
to be present in the liver, lung, macrophage cells, placenta, bone cells, embryonic
intestine, and aortic endothelial cells (Dusso et al., 1988;' Henry, 1992; Manoglesdorf
et al., 1984). The control of the extrarenal Io-hydroxylase enzyme is not PTH sensitive
(Henry, 1992). It thus appears that the Ire-hydroxylase has a ubiquitous distribution and
it is thus not surprising that it is present in bat renal tissue.
The experiments provided data which indicate that fruit bats possess an active Io-
hydroxylase enzyme in kidney tissue, and are able to convert 25(OH)D to 1,25(OIHhD.
5.5 Conclusion
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CHAPTER 6
The purification of the vitamin D binding protein from the fruit bat
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6.1 Introduction
In section 3.2.2, the bat was shown to have measurable levels of serum 1,25(OH)zD,
but undetectable levels of 2S(OH)D. Possible explanations for this phenomenon could
include:
1) that the bat does not metabolise vitamin D in the usual way, possibly by-passing
the formation of 25(OH)D,
2) that the bat does not possess a vitamin D binding protein, thus markedly
reducing the circulating levels of 25(OH)D or
3) that the binding properties of the vitamin D binding protein (PBP) are dnterent
from those of DBP in other mammals.
The first explanation appears unlikely as in section 4.3 it was shown that the bat is able
to metabolize [3H]-vitamin D3 to [3H]-25(OH)D3and is able to convert [3H]-25(OH)D3
to [3H]-lj25(OH)zD3. Furthermore the kidney possesses t1'.e Io-hydroxylase enzyme,
whose substrate is 2S-0HD.
Pilot experiments to assess the most appropriate techniques to purify DBP from serum
were performed using baboon serum which was readily available in our laboratory.
Later, experiments were conducted on pooled bat serum samples. Serial column
Thus attention was directed to determining whether or not the bat had a specific vitamin
D binding protein, and if so, to characterise the binding protein.
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chromatographic techniques were employed in conjunction with a number of DBP
identification techniques. The column chromatography techniques used were Affigel
Blue chromatography followed by DBAE Sephacel chromatography (Gianazza et al.,
1982; Taylor, 19&6). The DBP identification techniques used were immunodiffusion,
eII]-25(OII)D3 binding, and finally SDS gel electrophoresis combined with western blot
analysis.
o
6.2.1 Ouchterlony Immunodiffusion
6.2 Methods used in the I~mnnodiffusion Studies
Immunodiffusion studies were performed on human, baboon, chick, rabbit and bat
serum samples. Furthermore, during the purification steps of the baboon and bat DP:P
;rilctons off the columns were assessed using this technique for the presence of DBP.
Ouchterlony immunodiffusion (Garvey et al., 1977) was used to test the cross reactivity
of the DBP from different species with an anti-human D~r antibody.
A 2% agarose solution was prepared by dissolving two grams of agarose (Litex,
Denmark) in 100 ml of a O.05M sodium barbital buffer pH 8.6. Ouchterlony
immunodiffusion plates were prepared in 6 em disposable Petri dishes, by pouring a 1%
agarose gel which was prepared by mixing 3.3 m1 of 2% agarose and an equal volume
of the sodium barbital buffer. The agar was allowed to set. overnight at 4°C in a
hydrated container. A circle of six wells, each with a 5 I.d capacity was punched, using
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a cutter and template kit (Miles Laboratories, England). A seventh well was punched
in the centre of this circle, and into this well the antibody (5 Jot1), anti-human Gc-
globulin (60 ,.d/ml) (Dako Laboratories, Denmark), was pipetted. The frac.ions (5 Jotl)
to be assayed for DBP activity were pipetted into the outer wells.
6.2.2 Radial Immunodiffusion (RID)
To quantitatively measnre DBP, a 1% radial immunodiffusion (RID) plate (Garvey et
al., 1977), was poured as described in section 6.2.1 except that anti-human Gc-globulin
was added to the agarose, (3.3 ml of the 2% agarose, 3.2 ml O.05M sodium barbital
buffer pH 8.6 and 100 Jotlof the anti-DBP antibody). The agar was allowed to set
before 32 wells (5 ,ul)were punched. A human Go-globulin standard (Sigma, St Louis)
was diluted with distilled water to produce a range of standards from 5-60 Jotg/mI.The
fractions to be assayed for DBP activity were applied neat and diluted 1/10, 1/100 and
1/500 into different wells so as to ensure the detection of a possible ring.
For both the Ouchterlony and RID plates, maximum diffusion of protein into the agar
was completed after a. 48 hour incubation at 4°C in the hydrated container. The wells
were then filled with molten agarose and the plates washed in SL 0.3M NaCl for 12
hours. The solution was changed to SL O.ISM NaCl for a further 12 hours and the
plates were then extensively washed in distilled water for two hours, prior to staining
with 0.1 % Coomassie blue in 45% absolute alcohol, 10% acetic acid and 45 % distilled
water for 15 minutes. The plates were de-stained in 10% acetic acid, 25% ethanol,
65% H20 until all background staining has boon removed.
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Vigore 17.
(a) The cross reactivity of bat, baboon, chick, rabbit and human sera to antihuman
DBP antibody using the ouchterlony immunodiffusion technique. The bat and
chick sera (wells 2 and 4 respectively) show a spur effect.
(b) Purified bat DBP fractions in wells 1 (37-51), 5 (52-58) and 6 (5-10). Human
and baboon' DBP are in wells 2, 3 and 4 respectively. Purified bat DBP
(fraction 5-10) in wells 1, 3 and 5. A blank, human DBP and baboon DBP are
in wells 2, 4 and 6 respectively, and spur effects between bat and baboon as
well as bat and human are evident.
(c) Wells 2 and,4 contain human serum, well 3 contains the purified baboon DBP.
The 3 bat pools off the Affigel Blue column are in wells 5,6 and 1 (52-59,5-10
and .37-51), cross reactivity with human DBP antibody, occurred in bat pool
present in well 6 (fraction 5-10).
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A precipitation line on the Ouchterlony plates became visible between the antibody and
antigen in the agar (Figure 17). The rings around the wells in the RID plates were
measured on a TG Calibrating Viewer (Transidyne General Corporation, Ann Arbor,
Michigan) and the square of each of the diameters calculated. A g:.''I'h was drawn of
the concentration of human DBP standards against the square of the ring size of each
of the standards. The concentration of DBP in the serum samples was read off t.he
graph, having calculated the square of the diameters for each of the samples.
6.2.3.1 [3H]-25(OR.ID3binding studies
6.2.3 ~dentification techniques to determine DBP activity
The fractions collected off the Affigel Blue chromatography column (see Section 6.2.4
and 6.3.3.1) were assessed for [3H]-25(OH)D3binding activity (Imawari and Goodman,
1977).
Aliquots (400 1-'1) from appropriate fractions were pipetted into test tubes and incubated
with 10 000 cpm fH]-25(OH)D3 (30 pg (160 Ci/mmol Amersham) in 50 ~l ethanol).
Included in this assay was a blank containing only 400 ,ttl O.03M sodium phosphate
buffer pH 7.0 plus [3H]-25(OH)D;;. The tubes were incubated at 4°C for 2 hours, after
which 200 ,ttlcharcoal! dextran solution (Section 3.1.1.2) was added to each of the tubes
except for a second blank pair to which was pipetted 200 ,ttlof buffer. The tubes were
centrifuged at 3000 rpm for 10 minutes. Aliquots (500 f..d)from each were transferred
into counting vials, scintillant was added and each vial counted for 5 minutes.
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6.2.3.2 Albumin determination
Albumin was measured by the method described by Doumas et al. (1971). A 0.06M
solution of bromacresol green (BCG) pH 4.2 and O.IM succinate buffer pH 8.4 were
prepared. One part BCG was diluted with three parts succinate buffer to produce a
working dye solution. A 25 pI sample of each fraction to be measured was diluted with
5 ml working dye solution. Included in the experiment was a known albumin standard
(34 gIL) and a reagent blank. The tubes were vortexed and incubated for 5 minutes at
room temperature before absorbances were measured at 628 nm in a dual beam
spectropbotometer, The albumin concentration of the fractions was calculated and
reported as gIL.
6.2.3.3 Total protein estimation
The total protein was measured using the Lowry Folin method of Lowry et al..(1951),
which was modified to measure microgram concentrations of protein. A bovine serum
albumin standard (Sigma, St Louis, 0.3 mg/ml) was diluted over the range 0-0.3
mg/ml, The fractions to be measured for total protein were diluted 1150 with H20. To
100 p.l of each cf the standards and fractions in duplicate, 500 p.l of a mixture of 2%
disodium hydrogen carbonate (Na2(HC03h, 1% copper sulphate and 2% sodium
potassium tartrate in the ratio of :::~:0.5:0.5 was added.
Exactly 15 minutes later 50 p.l of Folin' s reagent diluted 1:1 with H20 was added. The
tubes were vortexed and incubated in a dark cupboard for 30 minutes. Absorbances
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were read at 750 nm and a graph drawn. The total protein was calculated taking into
account the dilution factor of each of the fractions and their concentrations were
reported in J.tg/ml.
6.2.4 Purification of DBP from serum using affigel blue chromatography
An estimation of protein concentrations was also determined by measuring the
absorbances of fractions in a dual beam spectrophotometer at 280 nm.
To purify DBP a 5 m1 pool of either baboon (Ross et al., 1982) or bat serum was
dialysed against 4 litres of a 0.03M sodium phosphate buffer pH 7.0, over 24 hours.
The serum was then centrifuged at 3 000 rpm for 10 minutes at 4°C, to remove any
precipitated material.
A 2.6 x 9 em column was packed with an Affigel Blue slurry (50-100 mesh, Bio-Rad)
and equilibrated with 0.03M sodium phosphate buffer pH 7.0 (Gianazza et al., 1982).
The dialysed serum sample was loaded onto the column at a flow rate of 1 ml/minute
and 4 ml fractions collected. The column was eluted firstly with O.03M sodium
phosphate (120 ml). Thereafter a linear gradient prepared with 20 ml 1M NaCI in
O.03M sodium phosphate buffer and 20 ml phosphate buffer, was used to elute further
proteins. This was followed by 20 ml of 1M NaCl. The final elution was performed
with 100 ml of O.SM sodium thiocyanate in 0.03M phosphate buffer pH 7.0.
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To determine total protein content of each fraction, its absorbance was measured on a
dual beam UV Spectrophotometer fi:'yeUnicam at 280 nm (Fruton et at, 1958). DBP
was measured using RID (Section 6.2.2), E~H]-25(OH)D3binding was assessed as
described in Section 6.2.3.1 and albumin measured as described in Section 6.2.3.2.
The fractions which contained the DBP were pooled and Iyophilized and stored at -
20°C until required for further purification.
6.2.5 Ion exchange chromatography
A 1 x 30 em Pharmacia column was packed with DEAE-Sephacfl (Pharmacia) using
O.SM Tris pH 7.5 as the equilibrating buffer at a flow rate of 0.3 ml/minute, as
described by Taylor (1986). The lyophilysed fraction from the Affigel Blue
chromatography containing DBP was dissolved in starting buffex (2 ml) and loaded onto
the column. Ten fractions (10 ml) were collected and this was followed by a 0-0.4M
NaCl gradient in the Tris buffer, 20 fractions (10 m1) were collected and the protein
determined in all the fractions by absorbances at 280 nrn.
The fractions were assayed for DBP activity using RID (Section 6.2.2) and by Western
immunoblotting (Section 6.2.7).
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6.2.6 SDS polyacrylamide gel electrophoresiuSDS-PAGE1
Electrophoresis as described by Laernmli (1970), was performed using a Mini
PROTEAN II dual slab cell system (Bio-Rad, Richmond, CA). Two 15% separating
gels, 75 mm thick were poured using the following reagents: 5.0 ml acrylamide, N,N-
methylene-bis-acrylamide (bis.s": /h.mide, 0.8:30 g/100 ml) (Bio-Rad), 3.75 mllM
Tris pH 8.8,0.65 ml H20, 0.1 mllO% sodium dodecyl sulphate (SDS) (Serva) and 0.5
m1 1.5% ammonium per- sulphate (APS) (Bio-Rad). To polymerize the gel 7.5 f.tl
tetramethylethylenediamine (TEMED) was added. The solution was syringed as quickly
as possible to a height of 120 mm between two glass plates, which were clamped
together in the Bio-Rad gel pouring system. To allow for even polymerization a small
volume of distilled water was carefully layered over the top of the gel. Once the gel
had set this was removed.
A 4% stacking gel solution was prepared using the following reagents; 1 ml acrylamide
(bis.acrylamide, 0.8:30 g/100 ml), 0.95 mllM Tris pH 6.8, 4.65 ml H20, 0.5 m180%
glycerol (BDH), 0.075 ml10% SDS and 0.35 ml1.5% APS. To polymerize the gel
20 f.tlTEMED was added. A ten space comb was placed between the glass plates 2 mm
above the separating gel. The stacking solution was syringed in between the glass plates
and around the spacer which formed the wells (20 ILl)into which the samples were
loaded.
The samples for electrophoresis were diluted to an approximate concentration of 10-25
p.g protein per well. An equal volume of sample buffer containing 0.125M Tris, 10%
,;;')
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b-mecaptoethanol, 4.6% SDS, 40% sucrose pH 6.8 (BDH) and 0.01 % bromphenol blue
as a tracking dye was added to each sample and the proteins denatured by heating in
a boiling water bath for 5 minutes. The samples were then cooled and loaded into the
wells with a micros yringe. The running buffer (0.025M Tris, 0.192M glycine and 0.1 %
SDS) was placed ii.to the lower and upper buffer chambers and the gel was run under
constant voltage with a Bio-Rad power pack model 3000/300, at 200 volts until the dye
front was just visible at the bottom of the gel.. The :!,elwas removed from the system
and stained for 10 minutes in a Coomassie blue stain (1.25 g Coomassie blue, 250 rnl
methanol, 50 ml acetic acid and 200 ml H20) prior to de-staining in a 10% acetic acid,
10% methanol and 80% H20 solution until all background colour had been removed
and only the protein bands were visible.
6.2.7 Immunoblotting: Western Blot Ana1y~is
Fractions to be analyzed were diluted to a final protein concentration of 1 mg/ml. Two
15% SDS acrylarnide gels were poureo and parallel sets of the fractions loaded into
corresponding wells in each of the gels. The proteins were electrophoresed and one of
the gels was stained with Coomassie blue. The other was electrophretically transferred
to a 0.45 p.m nitrocellulose sheet using the standard Bio-Rad immunoblotting system
(Tsang, 1983). The nitrocellulose sheet was presoaked in the transfer buffer (0.024M
Tris, 0.192M glycine, 20% methanol), lowered on the gel which in tum had been
placed on filter paper on a fibre pad. A second filter paper and fibre pad were overlaid
and the cassette closed. The gel holder was placed into the tank together with an ice
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pack and filled with transfer buffer. The proteins were transferred. at 80 rnA 10.1.' ~O
rmnutes.
The nitrocellulose sheet was removed and washed using 0.14M phosphate buffered
saline (PBS), 10% Carnation Instant Non-Fat Dry Milk and 0.3 % Tween*20 while
gently shaking at room temperature for 1 hour. The strip was incubated for 1 hr in 40
/-,1DBP antibody, 20 ml PBSr 10% dry milk and 540 /-,1Tween*20 with gentle shaking
and then washed three times with 25 ml PBS, 0.3% Tween*20. The final incubation
solution, containing 200 /-,1peroxidase-conjugated swine anti-rabbit immunoglobulin
complex (Dako) diluted with 20 ml PBS, 10% dry milk and 540 fLlTween*20, was
added to the strip and was left shaking for 1 hour at room temperature. Following three
5 minute washes with 25 ml PBS, the colour was developed with 3 mg
diaminobenzidine tetrahydrochloride (DAB) (Merck) and 8 /-,1H202 per 15 ml PBS. The
colour development was stopped with extensive distilled water washes.
6.3 Results
6.3.1 Ouehterlony immunodiffusion of five different serum samples
The serum samplesf bat, baboon, chick, rabbit and hum•.H) v/ <ch were assessed for
DBP activity against the human antibody (Go-globulin, D. Q) showed that all five sera
cross reacted to this antibody. This result is shown in Figure 17(a). The bat and chick
serum samples in wells number 2 and 4 respectively showed a spur effect to the human
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antibody. The other samples (baboon, rabbit and purified human DBP) in wells 3, 5
and 6 showed cross reactivity to the antibody without the spur effect visible.
Thus bat serum contained a protein which cross reacted immunologically with the
human DBP antibody. This result suggested that the bat has a vitamin D binding
protein, which has immunological similarity to the human protein.
6.3.2 Results of the purification of baDoonDBP
Baboon DBP identified by RID (Section 6.2.2) was present in fractions 10-45. The
maximum DBP activity was measured in fractions 18 and 42 with concentrations of 60
mg/L and 57 mg/L respectively. Using the binding of [3H]-25(OH)D3 (Section 6.3.1)
The fractionation of baboon serum on Affigel column chromatography gave four protein
peaks which eluted in fractions 5-10, 37-42, 43-51 and 52-59, as shown in Figure 18.
as another indicator of DBP activity, there were two distinct binding peaks (Figu
The first occurred between fractions 8 and 36, and the second between fractions
( .
I
I.
The SDS PAGE electrophoresis results of the five pooled fractions 5-10, l l-oo, .:17-42,
43-51 and 52-59 are shown in Figure 19. A protein of similar molecular weight to pure
baboon DBP was present in the pooled fractions 11-36 and 37-42. The last two
absorbance peaks (43-51, 52-59) eluted off the column were predominantly albumin
(Figure 18). Using the RID technique and human DBP as a standard (60 mg/L), most
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Figure 18.
Affigel Blue column chromatography of baboon serum. A 2.6 x 9cm column was
packed with Affigel Blue and 70 fractions (41I1l)were collected. The fractions were
each assessed for total protein at 280nm H,albumin f--1 and [3H]-25(OH)D3 binding
~--~. 5 peaks; fractions 5-10, 11-36, 37-42, 43-51 and 52-59 were noted.
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Figure 19.
15% SDS-PAGE electrophoresis of the pooled fractions obtained after Affigel Blue
chromatography of baboon serum. Poo12 (11-36) contained a single band which was
identified as DBP by RID.
;~D8?
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of the DBP eluted in fractions 11-36. The apparent concentration of baboon DBP in this
pooled fraction was 47.5 mg/L. The cross reactivity of the baboon DBP to the human
antibody is clearly shown in Figure 17 (b and c) of a Ouchterlony immunodiffusion
plate.
The total protein content of the pooled fraction 2 (11-36), measured by the Lowry
method (Section 6.2.3.3) was 36.3 giL.
6.3.3.1 Affigel chromatography of bat serum
6.3.3 Purification of fruit bat DBP
The analogous Affigel column separation of bat serum yielded three protein absorbance
peaks, fractions 5-10, 37,,51 and 52-58 (Figure 20). The second and third peaks were
again identified mainly as albumin (Figure 20). Binding studies using [3H]-25(OH)D3
(Section 6.2.3.1) showed binding widely distributed in fractions 4-55, with poorly
defined peaks present indicative of poor binding to [3H]-25(OH)D3• Using R1D as a tool
for identification of DBP activity, immuno reactivity was not detected in any of the
individual fractions.
However when the three pools (pool 1 (5-10), pool 2 (11-36) and pool 3 (37-58» were
concentrated and assayed separately for DBP activity using Ouchterlony
immunodiffusion, cross reactivity to the human DBP antibody WdS shown to be present
in pool 1, fractions ~-10 (Figure 17 (b».
II
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Figure 20.
Affigel Blue column chromatography of bat serum. 70 fractions (4ml) were collected
and each assessed for .otal protein absorbance at 280 nm (-~ ~ablumnin (-~ and [3H]~
25(OH)D3 activity t-·~.The 3 fractions pooled were 5-10, 11-36 and 37-58.
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Figure 21.
15% SDS-PAGE electrophoresis of the pooled fractions obtained after Affigel Blue
chromatography. The bat DBP eluted in pool 1 (5-10).
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Figure 22.
15% SDS-PAGE electrophoresis of human DBP (lane 5) and bat DBP (lane 9), run
against molecular weight standards (lane 2).
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Figure 23.
The determination of the relative molecular weights of the bat and human DBP
determinated by SDS-PAGE electrophoresis. Human DBP had a mw of. .J and bat
DBP had a mw of 61 600, using information extrapolated from figure 22).
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6.3.3.2 Identification of the bat DBP after DEAE sephacel chromatography
I using immunodiffusion
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Electrophoresis was performed using known molecular weight standards, commercial
human DBP and the partially purified baboon DBP, plus the three fractions off the bat
Affigel column chromatography (Figure 21 and 22). There appeared to be a major
protein band present in pool 1 (fractions 5-10) which migrated differently to the human
DBP (Figure 22). This pool showed cross reactivity to the human DBP 'ntibodyas
shown in Figure 17(b).
The molecular weight of this major protein was determined by the known MW marker
proteins to be 61 600 Daltons as shown in Figure 23. This protein was considered to
be fruit bat DBP by its immuno cross reactivity to the human DBP antibody (Figure
17). The size of the human DBP as determined in this same experiment was 56 340
Daltcns (Figure 23).
In a further purification step of the pooled fraction 5-10 off the affigel column, the bat
DBP eluted off the DEAE Sephacel column in fractions 18-21 as shown in Figure 2Lk
These fractions showed poor immuno-reactivity to the antibody by RID.
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Figure: 24.
DEAE-Sephacel chromatography of the parually purified bat DBP. 30 fractions (10ml)
were collected and absorbance of each measured at 280nm. Fractions were assessed for
DBP activity by RID. Immune-cross-reactivity was shown to be present in fractions 18-
21.
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Figure 25.
Western Immunoblot of the partially purified bat and baboon DBP.
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6.3.3.3 Bat DBP id~ntification by Western Blot
reactivity to the human DBP antibody (Figure 25).
Fractions 18-21 off the DEAE Sephacel column were electrophoresed and western
immunoblotted onto nitrocellulose. Fractions 18 and 19 showed strong immuno cross
1'5.4 Discussion
Vitamin D and its metabolites in the serum are bound to a specific carrier protein. On
investigation, the bat was found to possess a vitamin D binding protein. Fruit bat
vitamin D binding protein appears to be different from those of other mammals, in that
it eluted differently to baboon DBP on Affigel chromatography, on SDS
1984),
electrophoresis, and on Western immunoblotting,
Immunodiffusion and immunoblotting confirm the presence of a substance that cross
reacts with human DBP antibody and thus it is assumed to be DBP. Bats therefore like
all other animals with skeletons have a circulating DBP that is capable of sterol binding
with the, various vitamin D metabolites (Hay and Watson, 1976 a and b; Hac .lad,
Although DBPs are phytogenetically conserved (Hay and Watson, 1976 a and b;
Haddad, 1984), small differences in DBP structure and their binding properties may
occur (Hay and Watson, 1976 a and b; Haddad, 1984). Fruit bat partially purified DBP
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(61 6001» has a higher molecular weight than that reported for humans which was
assessed at 58 OOODby Haddad (1987) or at 56 340D in our laboratory.
Furthermore, cross reactivity of fruit bat DBP with the human antibody was poor,
showing a spur effect on immunodiffusion which again confirms the fruit bat DBP is
not identical to that of primates.
The fruit hat like many other animals such as fish, reptiles, birels and monotremes
appears to have a DBP present (Hay and Watson, 1976 a and b). Fruit bat DBP does
show poor binding to 25(OE-J)D (Figure 20), thus it is possible that 25-0HD in the bat
is; circulating largely in its free form, which could account for the undetectable serum
concentration.
Low affinity of DBP for vitamin D metabolites could lead to an increase metabolic
clearance of 25(OH)D (Bouillon, 1991) primarily through catabolism in the liver.
No comment can be made about the affinity of the bat DBP for any of the vitamin D
metabolites as studies in this direction were not undertaken.
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6.5 Conclusion
The fruit bat does have a detectable vitamin D binding protein. This binding protein has
a molecular weight of 6160C:.. which is higher than that of the human (56 340D). It
does however have some similarity to human DBP. This fact is demonstrated by its
cross reactivity (although poor) to the human DBP antibody by immunodiffusion
analysis.
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CHAPTER 7
The Utilisation of Vitamin D2 or Vitamin D3 by the Fruit Bat
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7.1 Introduction
Having demonstrated that the bat has measurable levels of serum 1,25(OHhD and that
the animal is able to convert vitamin D to 25(OH)D and 1,25(OH)J), the source of
vitamin D to nocturnal free-living frugivores was still unclear.
Vitamin D3 is exclusively formed in the skin of animals under the influence of UV
light, while the vitamin Dz is dh tarily obtained by its formation from the UV
irradiation of ergosterol, a plant and fungal sterol. If the latter was shown to be the
major circulating form of the vitamin, it would suggest that the source of vitamin D in
the fruit bat is from plant material.
The question as to the source of vitamin D for the fruit bat remains unanswered.
It is possible, that the low ultraviolet light intensity during crepuscular foraging is
sufficient to facilitate vitamin D production. Evidence fo~.this is provided by an in vitro
study of vitamin D synthesis from 7-dehydrocholesterol. In Johannesburg although
maximum vitamin D synthesis occurs around midday, significant amounts of previtarnin
D were formed between 08hoo-09hoo and 16hOO·17hOO.It is thus possible that during
the summer months, sufficient UV light might be available to produce vitamin D in the
skin of bats in the early morning and evening (Pettifor and Holick - unpublished data
pets cornm). Alternatively, the bat might use a dietary source of this vitamin to
maintain circulatory levels of 1,25(OH)zD. Possibly dietary sources ate the fruit, that
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these animals eat which might contain ergosterol. Fungi are known to produce vitamin
D3 (Gardner t 1988) and these fruit symbionts might be the vitamin D3 source.
In order to determine whether endogenous vitamin D and metabolites in the serum of
the fruit bat was derived from a vitamin D2 or vitamin D3 source, serum 1,25(OH)zD
was separated into either D;2or D3 metabolites by HPLC.
7.2 Methods
7.2.1 Preparation of the serum samples
The experiment was done on three serum samples each prepared differently. These
were.- a pool sample of wild bat (1 ml) serum, a human (1 ml) sample and a human
(1 ml) serum sample to which was added 200 pg 1,25(OH)zD2/50 J.tl ethanol. A
standard of 200 pg 1,25(OH)zD2 plus 200 pg 1,25(OH)2D3 diluted in 50 J.tlethanol in
1 ml saline was used as a control.
The samples and standard were extracted, chromotographed as described in Section
3.1.1.1, and then subjected to HPLC (straight phase silica gel) using the solvent system
(hexane: methanol: dichloromethane (85:5:7.5») described by Jones (1980) which is
known to separate 1,25(OH)2D2 from 1,25(OH)2D3' Forty fractions (0.5 ml) were
collected, and evaporated to dryness.
(;l
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Figure 26.
(a) The separation of authentic 1,25(OH)zDz and 1,25(OH)zD3 eluted off HPLC
using the solvent system hexane.rnetharrol.dichloromethane (85:5:7,5) as
measured by absorbance at 264nm.
(b) Authentic 1,25(OH)zDz and 1,25(OH)zD3,
(c) human serum to which was added 1,25(OHhD2,
(d) human serum and
(e) bat serum.
The samples (b,c,d and e) were extracted and chromatographed by HPLC using the
solvent system described in (a) and the eluted fractions (O.5ml) were measun I in the
calf thymus receptor assay for 1,25(OH)zD activity. 100% binding of 3[H] 1,25(OH)zD3
is equivalent to zero concentration of the 1,25(OHh.D metabolite.
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As no radiolabelled 1,25(OHhDz was available, the presence of 1,25(OH)zD2 was
detected by the use of the receptor binding assay. Each fraction was redissolved in 100
p.l ethanol. Two 30 p.l aliquots of each fraction were assayed for 1,25(OH)zD activity
using the calf thymus receptor binding assay as described in Section 3.1, 1.3.
7.3 Results
7.3.1 Utilisation of vitamin D2-,.QLP...:;by the fmit bat
Figure 26(a~depicts the UV tracing of the fractions eluting off the HPLC column, after
having been loaded with authentic 1,25(OH)zD2and 1,25(OH)2D3' 1,25(OH)2D2eluted
in fractions 25-28 while 1,25(OH)2D3eluted in fractions 31-35. A clear separation of
the two metabolites was obtained.
The radio-receptor binding assay, utilized to detect 1,25(OH)zD2 and 1,25(OHhD3
yielded similar results (Figure 26 (e». Once again, clear separation of the two
metabolites was achieved.
Extraction and separation of the 1,25(OH)zD metabolites in normal human serum
yielded two distinct peaks, the first smaller peak in fraction 23 and the larger peak in
fractions 30-31 (Figure 26(d». Addition of authentic 1,25(OH)zDz to the serum prior
to extraction, resulted in a marked increase in the size of the early peak, indicating that
this peak was 1,25(OH)P2 (Figure 26(c».
,,;", .'/
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The extraction and chromotography of bat serum yiek' '3 two almost equally size peaks
at the elution position of 1,25(OH1D2 and 1,25(OH)2D3 (Figure 26(e).
7.4 Discussion
Although it has been established in Chapters 3, 4, 5 and 6 that fruit bats possess the
enzymes for D3 metabolism and naturally have measurable 1,25(OH):J), the source of
vitamin D is still not known. In the preceeding experiments an attempt was made to
~;ble sources of vitamin J).
muscn and ta,
obtained from the consumption of animal products namely
lJ72) or endogenously synthesized after UV irradiation of the
skin (Holick, 1984), whereas vitamin D2 is obtained from the consumption of irradiated
plant tissue (Boland, 1986), Recently bacteria have been shown to produce metabolites
(oxy- and glycosylated) of vitamin D3 (Gardner et al., 1988) and these metabolites are
thought to be a source of vitamin D3 in herbivorous mammals (Gardner et al., 1988).
Man, being an omnivore (consuming both plant and animal products) naturally has
serum concentrations of both vitamin D2 and D3 metabolites (Mawer, 1972). Vitamin
D3 levels are usually substantially nigher than the vitamin D2 as man maintains his
vitamin D status primarily by obtaining the required vitamin D from the ronversion of
7~dehydrocholesterol to vitamin D under the influence of UV light, T i diet generally
contains little vitamin D unless the food is fortified (see Section 1.3). Human serum in
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this study, showed measurable amounts of 1,25(OH)zD2 and 1,25(OH)zD3 (Figure
26(d»; with 1,25(OH)zD3 levels being approximately twice that of 1,25(OH)2D2'
Some rr ammals discriminate against vitamin Dz metabolites; the turkey (Horst et al.,
1981) and pig (Horst et a1., 1982) have no detectable 25(OH)Dzl but measurable
25(OH)D3 levels (17.9 and 44.4 ng/ml respectively). The cow (Sommerfeldt et al.,
1980) and chick (Horst et al, l 1981) do have some 25(OH)D2, but appear to favour the
25(OH)D3 form of vitamin D. The horse has both 25(OH)Dz and 25(OH)D3; both of
which being < 4 ng/ml (Horst et al., 1981), almost at non-detectable concentrations
when measured using acceptable assay methodology. Sheep on the other hand appear
to utilize both forms of vitamin D (Horst et al., 1981), although 25(OH)D2 appears to
be favoured.
When authentic 1,25(OH)zD2 and 1,25(OH)zD3 were eluted off the HPLC (Figure
26(a» and assayed (Figure 26(b» the peak 1,25(OH)2D2occurred at fractions 25"28 and
the 1,25(OH)zDg at fractions 31"34. Bat serum shows similar peaks (Figure 26(e» in
fractions 24-27 and 31~32. These data clearly suggest the presence of both 1,25(OHhD2
and 1,25(OH)2D3 in bat serum.
Thus, bats like many other animals (Horst et al., 1981) probably acquire vitamin D2
through the diet, but also produce some vitamin D3 endogenously. The skin of fruit,
a possible source of vitamin D2, is generally discarded by these animals. However it
is possible that during and after a meal while grooming (Chapter 1, Section 1.9),
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vitamin D2 is swallowed and although not directly chosen for the meal, the fruit skin
could be the source of this vital substance.
~ources of vitamin D,. may be more varied, gut flora (e.g, bacteria) might serve as a
source vi vitamin D:h as they do in other herbivorous mammals (Gardner et al., 1988).
Fungal growth on rotting fruit might also produce this vitamin which could then be
dietarily acquired (Gardener et al., 1988). Another possibility is that bats might be
unique amongst mammals and produce vitamin D3 by endogenous means in processes
that do not require the presence of ultraviolet light. This has yet to be tested.
7.5 Conclusion
the results of the preceeding study indicate that the serum of wild bats contain both
1,25(OH)2tJz and 1,25(OH)zD3• It is unclear how the bat obtains these two forms. It is
possible that vitamin D2 is obtained by dietary means from the skin of fruits. How the
bat obtains vitamin D, is unclear. It is possible that fungi are a dietary source of D3•
Alternately fruit bats might receive some U. V. light during their dawn and dusk forrays
to endogenously produce this substance. Further work in this area needs to be
performs "
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CHAP1CER 8
Vitamin D metabolism in fruit bats: a synopsis
j}
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All animals [invertebrates (Klever et al., 1988) and vertebrates (Norman, 1990)] require
and utilize vitamin D. The fruit bat is no exception to this generalization in that it has
the full complement of enzymes needed to use this endocrine system. However in the
wild, the fruit bat has no obvious source of this vital hormone and appears to be
naturally vitamin D deficient, without any pathological evidence that this presents
problems to the animal.
8.1 Vitamin D Status
The principal circulating form [25(OH)D; chapter 3J was undetectable. Serum levels
of 25(OH)D are routinely used as clinical indicators of vitamin D status (Audran and
Kumar, 1985; DeLuca, 1984) and the lack of detectable 25(OH)D serum concentrations
suggest an impoverished vitamin D status. Further evidence for this is the relative
proportions (1:1.7) of the more polar metabolites (24,25(OH)~ and 1)25(OH)2D)
produced after labelled 25(OH)D3 supplementation (Table 6). The greater degree of lex-
hydroxylase activity than 24 hydroxylase activity is indicative of a vitamin D deficient
state, Elevated Ic-hydroxylase activity could lead to the rapid conversion of available
Z5(OH)D3 and explain undetectable levels of this, the principal circulating metabolite.
Recently, however, undetectable levels « 4 ng/ml) of 25(OH)D have been reported in
several free ranging mammals [e.g. horses (Horst et al., 1981) and bathyergid mole rats
(Buffenstein et al., 1991)] with no obvious pathological effects. Other vertebrate phyla
most notably fish [cyclostomes (Lampreys), cartilaginous fish (sharks), teleosts (carp)]
and amphibia [bull frogs] also have members with undetectable 25(OH)D concentrations
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(Kobayashi et al., 1991; Takeuchi et al., 1991). These data suggest that 25(OH)D may
not be as accurate an indicator of vitamin D status (Walters, 1991), but rather, .the
active hormone, 1,25(OH)2D should be used as an indicator of vitamin D status. In 1HIlt
bats, 1,25(OH)zD was present in both captive and wild bats (Table 3). These serum
concentrations, however, (Table 3) are at the lower end of the normal range for
mammals (Horst et al.,1981; Audran and Kumar, 1985), This could reflect a natural
vitamin D deficient state, to which bats have adapted and which does not present
pathological problems. The low levels of 1,25(OH)zD, naturally present, are therefore
adequate to regulate physiological systems dependent on vitamin D and might indeed
reflect the animal's evolutionary status and long term adaptation to their habitat.
8.2 Vitamin D endocrine svstem
The vitamin D endocrine system appears to be phylogenetically conserved throughout
the evolutionary time frame, in that even inver oates (Weiner et al., 1979) and
primitive vertebrates appear to employ the full complement of enzymes (Kobayashi,
1991; Takeuchi et al., 1991). It is not surprising therefore that bats are similar to all
other mammals studied to date (Del.uca, 1984; Haddad, 1987; Norman, 1982; Skinner
et al., 1991). They possess the full complement of enzymes, as shown by the
conversion of [3H]vitamin D3 to [3H]-25(OH)D3'This inturn was further metabolized
to the active hormone, [3H]-1,25(OH)2D3(Chapters 4 and 5). Furthermore the binding
protein (DBP), (Chapter 6) necessary for a functional vitamin D endocrine system, was
present, and found to have a molecular weight of 61 600D (Chapter 6), This binding
protein is slightly larger than that known 'or man (Haddad, 1987) and for baboon (Ross
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et al., 1982). Size no doubt reflects species differences, as most species studied to date
possess DBPs with unique molecular weights. The difference in size are, however, not
thought to influence the functional properties of DBP (Haddad, 1987).
Opperman et al, (1990) have shown that fruit bats possess vitamin D dependant
calbindins in the classic target organs. These findings confirm that the vitamin D
endocrine system in fruit bats is not vestigial but rather is active, albeit at lower levels
of active metabolite than normal vitamin D replete mammals. These concentrations may
be su.ficient to regulate mineral. homeostasis.
8.3 Vi.tamin D metabol1sm
Vitamin D metabolism in fruit bats might be different to other mammals, in that
25(OH)D is undetectable in serum. These undetectable serum concentrations might be
explained by: 1) a limited vitamin D substrate and 2) stimulated Io-hydroxylase
activity. As the animals are not exposed to sunlight and only forage before dawn and
after dusk, they do not appear to have an endogenous source of vitamin D. The only
dietary source of vitamin D could be that obtained from skins of fruit and fungal
activity in rotting fruit. As there is only an intermittent and scarce supply of vitamin
D, the vitamin D substrate could thus be limiting and the small amounts of 2S(OH)D
produced from this substrate would be rapidly converted to the more polar metabolites.
Evidence that this is indeed the case, is that there is a graded increase in the production
of both the renal dihydroxylated metabolites with increased 2S(OH)D substrate (Table
6, Chapter 4).
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It is well documented that the Io-hydroxylase activity is elevated and the 24-(R)-
hydroxylase suppressed when the vitamin D supply is limited (Henry, 1992). Relative
ratios of the two renal vitamin D metabolites produced confirmed this to be true in the
fruit bats, for twice as rr.ach l,25(OHh.D is produced in comparison to 24,25(OH)2D
(Table 6, Chapter 4). Elevated Io-hydroxylase activity would use up the available
25(OH)L substrate and may explain the undetectable concentrations of 25(OH)D.
The regulation of vitamin D3 homeostasis in the. fruit bat appears similar to that
reported for other mammals (Fraser, 1980) including; subterranean mole rats,
(Buffenstein et al., 1991). In mole rats, which naturally have an impoverished vitamin
D st?hl'l the l-hydroxylase activity was significantly increased compared to that of the
24'- "droxylase activity (Buffenstein et al., in press). The production of both
24,25(OH)2D and 1,25(OH)2D increased with increasing doses of 25(OH)D
administered when vitamin D depleted animals received 25(OH)D3 (Chapter 4). The
levels at the lower dose of 25(OH)D3 given (2.1 ng/bat) were belo I the detectable
levels of l,25(OH)zD3 when measured in our receptor binding assay (section 3.1.1.3),
The concentrations of the active hormone 1,2S(OH)zD3produced during that experiment
(Table 6) was similar to those found in freshly caught wild bats (Chapter 3). This
finding suggests that wild populations of bats receive some vitamin D for animals given
the highest 25(OH)D3 supplement (21 ng/bat) had higher I,25(OH)2D concentrations
than freshly caught bats.
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In captivity the diet of the bats was strictly controlled in that 1110stof the fruit was
peeled and/or was washed. Fruit bats, kept on this diet without vitamin D3 exhibited
serum 1,25(OH)zD concentrations, which were 4 x less than that of the wild caught
animals; suggesting that the ~ungalcontamination of the unwashed fruit skin is a source
of vitamin D. In the serum of wild bats both 1,25(OHkD2 and 1,25(OH)2D3 were
detected (Chapter 7), thus showing that there are two sources of vitamin D for the fruit
bat. It is well documented that vitamin Dz is present in plants tissue, Boland (1986),
also found vitamin Dj-like substances present in plants which might explain the
presence of both vitamin Dz and D3 in bat serum samples (Chapter 7). Alternately
fungi, present in rotting fruit skins might be the source of vitamin D3 (Gardner et al.,
1988).
One can conclude that in the wild, vitamin D substrate is limited. Bats most likely do
not endogenously synthesize vitamin D but rather rely on dietary sources for this vital
compound.
8.4 Mineral homeostasis
Serum concentrations of calcium and magnesium in both freshly caught and I" 19 term
captive colonies (irrespective of vitamin D3 supplementation), were tightly regulated
(Table 3). These data confirm that even in the absence of vitamin D3 supplementation
and with the naturally undetectable 25(uH)D serum concentrations, the endocrine
system controlling mineral homeostasis functions adequately. This could imply that
calcium homeostasis in the fruit bat is independent of vitamin D status, however the
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tendency for serum calcium levels to be lower and to have greater variability in those
animals kept in captivity on a vitamin D deplete diet suggests that vitamin D might be
necessary, although the concentrations required appear to be lower than found in other
mammals.
8.5 Conclusion
Fruit bats appear to belong to a small group of animals that naturally have limited
access to vitamin D and have to be persimonious in their vitamin D metabolism. All
these animals are faced with no obvious source of vitamin D and/or inadequate
exposure of the dermal layer of skin to the ultraviolet light. The primary source of
vitamin D in fruit bats is therefore thought to be dietary, rather than endogenous
(Chapter 7). This source is however limiting, Withthe result that the available substrate
is converted to the active metabolite and little, if any, vitamin D is present in
circulation as 25(OH)D (Chapter 3). The quantity of 1,25(0H)2D produced, although
comparatively lower than in most mammals, is sufficient to ensure adequate function
despite the impoverished vitamin D status. The vitamin D endocrine system in fruit bats
,
I
is thus finely regulated and no different in (a) its complement of enzymes (Chapter 4
and 5), (b) its mode of serum transport (DBPs, Chapter 6), and (c) action [CaBP
(Opperman et aI., 1990) serum mineral homeostasis, (Chapter 3)] to that in other
mammals.
I
I
I
l The fruit bat is thus well adapted to face the ecophysiological problems encountered inits milieu, especially with respect to an absence of an obvious source of vitamin D.
166
Arnaud, S.B., Newcomer, A,D., Offord, K.P. and Go, V.L.W. (1979). 25··
Hydroxyvitamin D metabolism in non-tropical sprue. In: Vitamin D: Basic Research
and its rlinical Applications. (Eels. Norman A.W., Schaefer K., von Herrath D.,
Grigoleit H.G., Coburn J.W., DeLuca H.P., Mawer B.B., Suda T.), Walter de
Gruyter, New York, pp 1023-1025.
Audran, M. and Kumar, R. (1985). The physiology and the pathophysiology of vitamin
D. Mayo Clin. Proc. 60: 851-866.
Bell, N.H., Shaw, S., Turner, R.T. (1984). Evidence that 1,25-hydroxyvitamin D3
inhibits the hepatic production of 25-hydroxyvitamin in man. J. CUn. Invest. 74: 1540-
1544.
Bidmon, H.J, and Stumpf, W.E. (1991). Phylogeny of receptors for 1,25-
dihydroxyvitamin D3 (1,25-D3, soltriol) in vertebrates and invertebrates. In: Vitamin
D, Gene Regulation, Structure-Function Analysis and Clinical Application. (Eds.
Norman, A.W., Bouillon, R., Thomasset, M.) Walter de Gruyter, Berlin, pp 673-674.
Bikle, D.D., Siiteri, P.K., Ryzen, E., Haddad, J.G., with the technical assistance of
Gee, B. (1985). Serum protein binding of 1,25-dihydroxyvitamin D; Are-evaluation
by direct measurement of free metabolite levels. J. CUn. EOOo. and Met. 61: 969-975.
Bligh, E.G. and Dyer, W.J. (1959). A Rapid method of tota1lipid extraction and
purification. Can. 1. Biochem. Physiol. 37: 911-917.
Blunt, J.W., DeLuca, H.F. and Schaoes, H.K. (1968).25 Hydroxy-cholecalciferol: a
biological active metabolite of Vitamin D;?.Biochemistry 7: 3317-3322.
Boland, R.L. (1986). Plants as a source of vitamin D3 metabolites. Nutrition Rev. 44:
1-8.
11.1- .• ((
167
Boyle, L.T., Omball, r.L., Gray, R.W., et ",I. (1973). The biological activity and
metabolism of 24,25-dihydroxy-vitamin D3• Biol. Chem. 248: 4174-4180.
Bouillon, R., Allewaert, K., Tan, B.K., Van BeIn, H., De Clercq, P. and Vandewalle,
M. (1991). Biological activity of 1,25-dihydroxyvitamin D analogs: influence of relative
affinities for DBP and vitamin D receptor. In: Vitamin D, Gene Regulation, Structure-
Function Analysis and Clinical Applicaticn. (Eds. Norman, A.W., Bouillon, R.,
Thomasset, M.) Walter de Gruyter, Berlin, pp 131-138.
Brommage, R. and Baxter, C. (1988). Elevated calcium, phosphorus and magnesium
retention in pregnant rats prior to the onset of skeletal mineralization. J. Bone and Min.
Res. 3: 667-672.
Brown, A.r. and DeLuca, H.P. (1985). Production of 1O-oxy-19-nor-25-
hjr: 'oxyvitamin D3 by solubilized kidney mitochondria from chick and rat. J. Bioi.
Chern. 260: 14132-14136.
Buffenstein, R., Skinner, D.C., Yahav, S., Moodley, G.P., Cavaleros, M., Zachen,
D., Ross, F.P. and Pettifor, r.M. (1991). The effect of oral cholecalciferol
sUjJ_l:-.ementation at physiological and suproaphysiological doses in naturally vitamin D3-
deplete subterranean damara mole rats (Cryptomys damarensis). J. Endocnn. 131: 197-
202.
Buffenstein, R.; Jarvis, r.U.M., Opperman, L.A., Cavaleros, M., Hough, S. and Ross,
F,P. (1988). Vitamin D metabolism and expression in chthonic naked mole rats
(abstract). J. Bone and Min. Res. 3: S119.
Buffenstein, R. and Yahav, S. (1991). Cholecalciferol has 110 effect on calcium and
inorganic phosphorus balance in naturally cholecalciferol-deplete subterranean mammal,
the naked mole rat (Heierocephalus gZaber). J. Endocrin. 129: 21-26.
168
Buffenstein, R., gergeev, LN. and Pettifor, J.M. (in press). Vitamin D hydroxylases
and their regulation in a naturally vitamin D deficient subterranean mammal, the naked
mole rat Heterocephalus glaber. J. Endocrin.
Carpenter, T. (1989). Mineral regulation of vitamin D metabolism. Bone and Min. 5:
259-269.
Clark, S.A. and D'Ercole, A.J. and Toverud, S.U. (1986). Somatomedsn-Crinsulin
like growth factor I and vitamin Ddnduced growth. Endocrin; 11"': 1660-1665.
Chesney, R.W., Rosen, J.F., Hamstra, A.J., Smith, C., Mahaffey, K. and DeLuca,
H.F. (1981). Absence of seasonal variation of serum concentrations of 1,25-
dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J. CUn. Endo,
Metab. 53: 139-142.
Clements, T.L., Johnson, M.R. and Fraser, D.R. (1987). A new mechanism for
induced vitamin 1) deficiency in calcium deprivation. Nature 325: 62-65.
DeLuca, H.F. (1984). The metabolism, physiology, and function of vitamin D. In:
Vitamin D: Basic and Clinical Aspects. (Ed. Kumar) R.), Martinus Nijhoff Publishing,
Boston, pp 1-68.
Delvin, E.E. and Dussault, M. 11985). Kinetics of kidney mitochrondrial 25-
hydroxycholicalciferol l-hydroxylase in vitamin Dsrepleted weanling guinea pigs.
Archives. Biochem. Biophys. 240: 337-344.
Dusso, A., Lopez-Hilker, S., Rapp, N. and Slatopolsky, E. (1988). Extrarenal
production of calcitrol in chronic renal failure. In: Vitamin D, Molecular, Cellular and
Clinical Bndocrinology. (Eels. Norman, A.W., Schaefer, K., Grigoleit, G.H. and
Herrath, D.V.) Walter de Gruyter, Berlin, pp 112-113.
169
Doumas, T.B., Watson, W.A. and Briggs, H.G. (1971). Albumin standards and the
measurement of serum albumin with bromcresel green. Clin. Chim. AGT.tt. 31: 87-96.
Dueland, S., Peterson, J.L., Helgerud, P., et al. (1982). Transport of vitamin D3 frr rn
rat intestine: Evidence for transfer of vitamin D3 from chylomicrons to a-gl .ns. J.
Biol. Chern. 257: 146-150.
Eisman, J.A., Hamstra, A.J., Kream, B.E. and DeLuca, H.F. (1976). 1,25-
dihydroxyvitamin Din biological fluids: a simplified and sensitive assay. Science 193:
1021-1023.
Esvelt, R.P., Schnoes, H.K. and DeLuca, H.F. (1978). Vitamin D3 from rat skins
irradiated in vitro with ultraviolet light. Arch. Biochem. Biophys. 188: 282-286.
Fraser, n.R. ,1980). Regulation of the metabolism of vitamin D. Physiol. Rev. 60:
551-613.
Gardener, M.Z., Reinhardt, T.A. and Horst, R.L. (1988). Biological assessment of
vitamin D~metabolites produced by rumen bacteria. J. Steroid Biochem. 29: 185-189.
Garvey, I.S., Cremer, N.E. and Sussdorf, D.H. (1977). Methods of Immunology,
Third Edition, Addison-Wesley Publishing Company Inc., Advanced Book Program,
New York.
Gianazza, E. and Arnaud, P. (1982). Ch..romatography of plasma proteins on
immobilized cibacron blue F3-GA. J. Biochem, 203: 637-641.
Glisson and Whistler (1929), The history of rickets. In Rickets, Including Osteomalaoia
and Tetany, (Ed. Hess, A) Lee and Febiger, Philadelphia, pp 22-37.
lIaddad, J.D. and Chyu, h..I. (1971). Competitive protein binding radioassay for 25-
hydroxycholecalciferol. J. Glin. Bndocrinol. and Metab. 33: 992 995.
170
Haddad, J.G. and Birge, S.J. (1975). Widespread specific binding of 25-
hydroxycholecalciferol in rat tissues. J. Biol, Chem. 250: 299-303.
Haddad, J.D. (1984). Nature and functions of the plasma binding protein for vitamin
D3 and its metabolites. In Vitamin D: Basic and Clinical Aspects (Ed. Kumar, R.)
Martinus Nijhoff Publishing, Boston, pp 383-395.
Haddad, J.G. (1987). Traffic, binding and cellular access of vitamin D sterols. In:
Bone and MLeral Research. (Ed. Peck, W.A.), Elsevier Science, Berlin, volume 5,
pp 281-308.
Haddad, J.G. and Cooke, N.B. (1989). Vitamin D binding protein (Go-globulin). Endo.
Rev. 10: 294-307.
Halloran, B.P., Bikle, D.D., Levens, M.J.? Castro, M.E., Globas, R.K. and Halton,
E. (1986). Chronic 1,2.5-dihydroxyvitamin D3 administration in the rat reduces the
serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.
J. cu« Invest. 78: 622-628.
Harper, K.D., McLeod, J.F.; Kowalski, M.A. and Haddad, J.G. (1987). Vitamin D
binding protein sequesters monomeric actin in the circulation of the {at. Clin. Invest.
79: 1365-1370.
Haussler, M.R., Mangelsdorf, D.J., Komm, B.S., Terpening, M., Yamaoka, K.,
Allegretto, E.A., Balcer, A., Shine, J., McDonnel, D.P., Hughes, M., Weighel, N.L.,
O'Malley, B.W. and Pike, J.W. (1988). Molecular biology of vitamin D. Recent
Progress in Hormone Res. 44: 263-297.
Hay, A.W.M. and Watson, G. (1976a). The plasma transport proteins of 25-
hydroxycholecalciferol in fish, amphibians, reptiles and birds. Compo Physiol. Biol, 53
:3: 163-166.
171
Hay, A.W.M. and Watson, G. (19Ci6~), The plasma transport protens of 25-
hydroxycholecalciferol ill mammals. Compo Physiol. Bioi. 53 B: 167-172.
Hay, A.W.M. and Watson, G. (1977). Vitamin D2, invertebrate evolution. Compo
Biochem. Physiol. B. 56: 375-380.
Henry, H.L. (1980). Measurement of chicken kidney 25-hydroxyvitamin D3 1-
hydroxylase and 25-hydroxyvitamin D3 24-hydroxylase. Methods of Enzymology 67:
445-449.
Henry, H.L. and Norman, A.W. (1984). Vitamin D: metabolism and biological
actions. Ann. Rev. Nutr. 4: 493-520.
Henry, H.L. and Norman, A.W. (1990). Vitamin D: metabolism and mechanism of
action. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral
Metabolism (Ed. Favus, M.J.), The American Society for Bone and Mineral Research,
Kelseyville, California, pp 47-52.
Henry, H.L. (1992). Vitamin D hydroxylases. J. Cell. Biochem. 49: 4-9.
Heymann, V.I. (1937). Metabolism and mode of action of vitamin D II. Storage of
vitamin D in different tissues in vivo. J. Bioi. Chern. 118: 371-376.
Hess, A.F. and Gutman, M.B. (1922). Cure of infantile rickets by sunlight. 1. Amer.
Med. Assoc. 78: 29-30.
Hughes, M.R., Baylink, D.J., gonnerman, W.A., Toverud, S.V., Ramp, W.K. and
Haussler, M.R. (1977). Influence of dietary vitamin D3 on the circulating concentration
of its active metabolites in the chick and rat. Endocrin. 100: 799-806.
172
Holick, M..P. (1984). The photobiology of vitamin D3 in man. In: Vitamin D: Basic
and Clinical Aspects. (Ed. Kumar, R.), Martinus Nijhoff Publishing, Boston pp 197~
216.
Holick, M.F., Richtand, N.M., NcNeill, S.C., Holickf S.A., Frommer, J.E., Henley,
J.W. and Potts, J.T. Jr. (1979). Isolation and identification of pre-vitamin D3 from skin
of rats exposed to ultraviolet irradiation. Biochem. 18: 1003~1008.
Holick, M.F. and Clark, M.B. (1978). The photobiogenesis and metabolism of vitamin
D, Fed. Proc. 37: 2567··2574.
Horst, R.L., Littledike, E.T., Riley, J.L. and Napoli, 1.1.,. (1981). Quantitation of
vitamin D and its metabolites and their plasma concentrations in five species of
animals. Anal. Biochem. 116: 189-203.
Horst, R.L., Napoli, J.L. and Littledike, B.T. (1982). Discrimination in the
metabolism of orally dosed ergocalciferol and cholecalciferol by the pig, rat and chick.
J. Biochem. 204: 185-189.
Horst, R.L., Koszewski, N.J. and Reinhardt, T.A. (1988). Species variation of vitamin
D metabolism and action: lessons to be learnt from farm animals. In: Vitamin D
Molecular Cellular and Clinical Endocrinology. (Eds, Norman, A.W., Schaefer, K.,
Grigoleit, H.G., von Herrath, D.) Walter De Grnyter, Berlin, pp .
Huldshinsky, K. (1919). Heilung von raehitus dutch kunstliche hohensonne. Deut, Med.
Wochschr. 45: 712-713.
Hurst, R.O. (1967). A simplified approach to the use of determinants and calculations
of complex enzymes. Canadian Biochem. 45: 2015-2016.
173
Ichikawa, Y., Hiwatashi, A. and Nishii, Y. (1983). Tissue and subcellular distributions
of cholecalciferol 25 hydroxylase cytochrome P-450 D25 linked monooxygenase
system. Compo Biochem, Physiol. 75 B: 479-488.
Ikekawa, N. (1987). Structures and biological activities of vitamin D metabolites and
.eir analogs. Med. Res. Rev. 7: 333:...366.
Imawari, M. and Goodman, D.S. (1977). Immunological and immunoassay studies of
the binding protein for vitamin D and its metabolites in human serum. J. CUn. Invest.
59: 432-442.
Jones, G. (1980). Ternary solvent mixtures for improved resolution of hydroxylated
metabolites of vitamin Dz and vitamin D3 during high-performance liquid
chormatography. J. Chromat. 221: 27-37.
Kadowaki, 3. and Norman, A.W. (1984). Dietary vitamin D is essential for normal
insulin secretion from the perfused rat pancreas. J. Clin. Invest. 73: 759-766.
Kawashima, H. and Kurokawa, K. (1983). Unique hormonal regulation of vitamin D
metabolism in the mammalian kidney. Min. Elect. Metab. 9: 227-235.
Kiever, K.M'1 Draper, H.H. and Ronald, K. (1986), Vitamin D metabolism in the
hooded seal (Cystophora cristata). J. of Nut. 118: 332-341.
Knutson, J.C. and DeLuca, H.F. (1974). 25-Hydroxyvitamin D3-24-hydroxylase; sub-
cellular location and properties. Biochem. 13: 1543-1548.
Kobayashi, T., Takeuchi, A. and Okano, T. (1991). An evolutionary aspect in
vertebrates from the viewpoint of vitamin D3• In: Vitamin D, Gene Regulation,
Structure-Function Analysis and Clinical Application. (Eds, Norman, A.W., Bouillon,
R., Thomasset, M.) Walter de Gruyter, Berlin, pp 679-680.
174
Kraml, M. (1966). A semiautomated determination of phospholipids. Clinica et
Chemica Acta 13: 442-444.
Kronenburg, H.M. (1990). Parathyroid hormone: mechanisms of actions. In: Primer
on the Metabolic Bone Disease and Disorders of Mineral Metabolism. (Eli. k'~lVUS.,
M.J.)~;The American Society for Bone and Mineral Research. Kelseyville, Calitornls,
pp 44-46.
Kumar, R., Schnoes, H.K. and DeLuca, H.F. (1978). Rat intestinal 25-hydroxyvitamin
D3- and 1,25-dihydroxyvitamin D3-24-hydroxylas~. J. Bioi. Chem. 253: 3804-2809.
Kumar, R. (1984). Metabolism of 1,25-dihydroxyv,tamin D3• Physiol. Rev. 64: 478-
504.
Kumar, R. (1986). The metabolism and mechanism of action of 1,25-dibydroxyvitamin
D3• Kid. Int. 30: 793-803.
Laeinrnli, U.K. (1970). Cleavage of structural proteins during the assembly of the head
bacteriophage T4. Nature 227: 680-685.
Lam, H-Y., Schoes, H.K., DeLuca, ,H.P., et al. (1973). 24,25-dihydroxyvitamin D3
synthesis ana biological activity. Biochem. 12: 4851-4855.
Lehninger, A.L. (1975). The Molecular Basis of Cell Structure and Function:
Biochemistry. Worth Publishers, Inc. New York.
Lowry, O.H., Rosenboroug, N.J., Fair, A.L. and Randall, R.J. (1951). Protein
measurements with the folin phenol reagent. J. .Biol. Chem. 193: 265-275.
175
Manoglesdorf, D.J., Koeffler, H.P., Donaldson, C.A., Pike, J.W. and Haussler M.R.
(1984). 1,25-dihydroxyviiamin D3 - induced differentiation in a human promyelocytic
leukemia ce111ine(HL-60): Receptor-mediated maturation to macrophage-like cells. J.
Cell Biol. 98: 391-398.
Mawer, B., Backhouse, J., Holman, C.A., Lumb, G.A. and Stanburg, S.W. (1972).
The distribution and storage of vitamin D and its metabolites in human tissues. CUn.
Sci. 43: 413-431.
Minghetti, P.P, and Norman, A.W. (1988). 1,25(OH)-vitamin D3 receptors: Gene
regulation and genetic circulatory. FASEB J. 2: 3043-3053.
Monolagas, S.C., Hustmyer, F.G. and Yu Xiao-Peng (199v). Immunomodulating
properties of 1,25-dihydroxyvitamin D3. Kid. Int. 38 (Suppl, 29): S9-S16.
Morgenstein, S.G., Kessler, J., Auerback, R.V., Flow, and Klein, B. (1965). An
automated p-nitrophenylphosphate serum alkaline phosphatase procedure for the
autoanalyser. Clin. Chern. 11: 876-878.
Nemere, I., Leathers, V, and Norman, A ..W. (1986). 1,25-Dihydroxyvitamin D3 -
mediated intestinal calcium transport. Biochemical identification of Iysosomes
containing calcium and calcium-binding protein (calbindin-D 28k). J. Blol. Chern. 261:
16106-16114.
Norman, A.W" Roth, J. and Orci, L (1982). Vitamin D Endocrine System: Steroid
Metabolism, Hormone Receptors and Biological Response (Calcium Binding Proteins).
Endo. Rev. 3: 331-366.
Norman, A.Vol. and Litwack, G. (1987). The calcium regulating hormones: vitamin D,
parathyroid and calcitonin. In: Hormones. (Ed. Norman, A.W.) Academic Press, New
York, pp 3~6-396.
I,;:
176
Norman, A.W. (1990). Intestinal calcium absorption: a vitamin D hormone mediated
adaptive response. Am. J. Clin. Nut. 51: 290-300.
Opperman, L.A. and Ross, F.P. (1990). The adult fruit bat (Rousettus Aegyptiacus)
expresses only calbindin-Ds; (vitamin Dvdependent calcium binding protein). Compo
Biochem: Physiol. 97B: 295-299.
Pettifor, r.M. (1990). Recent advances in pediatric metabolic bone disease: the
consequence of altered phosphate homeostasis in renal insufficiency and
hypophospatemic vitamin Deresistant rickets. Bone and Mineral9~ 199-214.
Ponchon, G. and DeLuca, H.P. (1969), The role of the liver in the metabolism of
vitamin D. J. CUn. Invest. 48: 1273-1279.
Portale, A.A., Booth, B.E., Halloran, B.P. and Morris, R.C. (1984). Effect of dietary
phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and
immunoreactive parathyr .d hormone in children with moderate renal failure. J. CUn.
Invest. 73: 1580M1589.
Rasmussen, H., Fontaine, 0., Max, B.E. and Goodman, D.E.P. C 179). The effeft of
l-hydroxyvitamin D3 administration of calcium transport in chick intestine brush border
membrane vesicles. J. BioI. Chem. 254: 2993-2999.
Richard, J.L., Laverriere, J.N., Buisson, N., Tixier-Vidal, A. and Gourdj, D. (1991).
Kinetics ofTRH and 1,25 dihydroxyvitamin D3 (1,25.D3) interaction on the expression
of PRL and GH genes in GH3.E6 pituitary cells. In: Vitamin D, Gene Regulation,
Structure-Function Analysis and Clinical Application. (Bds. Norman, A.W., Bouillon,
R., Thomasset, M.) Walter de Gruyter, Berlin, pp 28-29.
Reichel, H., Koeffler, H.P., Bishop, J.E. and Norman, A.W. (1987). 25-
hydroxyvitamin D3 metabolism by lipopolysaccharide. Metabol. 64: 1-9.
177
Riechel, H., Koeffler, H.P. and Norman, A.W. (1990). The role of the vitamin D
endocrine system in health and disease. The New Eng. J. Med. 320: 980-991.
Reinhardt, T.A., Horst, R.L., Littledike, B.T. and Beitz, D.C. (1982). 1,25-
Dihydroxyvitamin D3 receptor in bovine thymus gland. Biochem. Biopltys. Res.
Commun. 106: 1012-1018.
Reinhardt, T.A., Horst, R.L, Orf, J.W. and Hollis, B.W. (1984). A Microassay for
1,25-dihydroxyvitamin D not requiring high performance liquid chromatography:
application to clinical studies. J. Clin Endocrin. and Metab. 58: 91~98.
Rosenstreich, S.J., Rich, C. and Vilwiler, W. (1971). Deposition in and release of
vitamin D3 from body fat: evidence fora storage site in the rat. J. Clin. Invest. 50:
679-687.
Ross, F.P., Pentopoulos, M, and Pettifor, I.M. (1982). Purification and properties of
baboon serum vitamin D binding protein. In: Vitamin D, Chemical, Biochemical and
Clinical Endocrinology of Calcium Metabolism. (Eels. Norman A.W., Schaeffer K.,
von Herrath D., Grigoleit H.G.), Walter de Gruyter, Berlin, pp 1191-1193.
Schaafsma, G., Visser, W.L., Dekker, P.K. and van Schalk, M. (1988). Effect of
dietary calcium supplementation with lactose on bone in vitamin D-deficient rats. Bone
8: 357-366.
Skinner, D.C., Moodley, G. and Buffenstein, R. (1991). Is vitamin D:; essential for
mineral metabolism in the Damara mole rat iCryptomys damarensisyt Gen. and Camp.
Endo. 81: 501-505.
Sommerfeldt, r.L., Horst, R.L., Napoli, J.L., Beitz, D.C. and Littlediek, E.T. (1980).
Evidence for in-vitro production of vitamin D2 and vitamin D3 metabolites by rumen
microbes. J. Dairy Science 63 (Suppl. 1): 88-89.
o .1/ 1• .1
178
Smithers, R.H.N. (1983). The Mammals of the Southern African Subregion. University
of Pretoria. Pretoria.
Smith, J.E. and Goodman, D.S. (1971). The turnover and transport of vitamin D and
of apolar metabolite with the properties of 2S-hydroxycholecalciferol in human plasma.
J. CUn. Invest. 50: 2159-2167.
Steenbock, H. and Black, A. (1924). Fat-soluble vitamins. Xlll. The induction of
growth-promoting and calcifying properties in a ration by exposure to ultraviolet light.
J. Biol. Chern. 61: 405-422.
Stumpf, W.E., Sar, M., Reid, l'i.A., Tanaka, Y. andDeLuca,H.F. (1979). Target cell
for 1,25-dihydroxyvitamin D3 in intestnial tract, stomach, kidney, skin, pituitary and
parathyroid. Science 206: 1188-1190.
Stumpf, W.E. (1988). The endocrinology of sunlight and darkness. Complementary
roles of vitamin D and pineal hormones. Naturwissenschaften 75: 247-251.
Stumpf, W.E. (1991). The steroid hormone of sunlight soltriol (vitamin D) as a
seasonal regulator of bioligica1 activities and photoperiodic rhythms. J. Steroid.
Biochem. Mol. BioI. 29: 283-289.
Takeuchi, A., Okano, T. and Kobayashi, T. (1991). Vitamin D3 in cartilaginous fish:
Identification, quantitation and metabolism of vitamin D3• In: Vitamin D, Gene
Regulation, Structure-Function Analysis and Clinical Application. (Eels. Norman,
A.W., Bouillon, R., Thomasset, M.) Walter de Gruyter, Berlin, pp 681-682.
Tanaka, Y., Frank, H. and DeLuca, H.F. (1972). Role of 1,25-
dihydroxycholecalciferol in calcificati?n of bone and the maintenance of serum calcium
concentration in the rat. J. Nutr. 102: 1569-1577.
179
Tanaka, Y. and Del.uca, H.F. (1973). The control of vitamin D by inorganic
phosphorus. Arch. Biochem; Biophys. 154: 566-574.
Tanaka, Y., Castillo, A. and DeLuca, H.F. (1976). Control of renal vitamin D
hydroxylase in birds by sex hormones. Proc. Nt-.~t.Acad. Sci. USA. 73: 2701-2705.
Tsoukas, C.D., Provendini, D.M. and Manolagas, S.C. (1984). 1,2S·.nihydroxyvitamin
D3, a novel immunoregulatory hormone. Science, 224: 1438-1440.
Turnbull, H., Trafford, D.r.H. and Maikn, H.L.K. (1982). A rapid and simple method
for the. measurement of plasma 25(OH)~ and 25(OH)D3 using Sep-pak C-18 cartridges
and a single high-performance liquid chromatography step. CUn. Chim. Acta 120: 65-
76.
van der Westhuizen, J., Fetnana des-Costa, F. and Metz, J. (1982). Cobalamin
inactivation by nitrous oxide produces severe neurological impairment in fruit bats:
protection by methionine and aggravation by !i1>olates.Life Sciences 31: 2001-2010.
Walters, M.R., Kollenkirdcn, U. and Fox, J. (1991). The semantics of vitamin D
deficiency. In: Vitamin D, Gene Regulation, Structure-Function Analysis and Clinical
Application. (Eds, Norman, A.W., Bouillon, R., Thomasset, M.) Walter de Gruyter,
Berlin, pp 708-709.
Windaus, A., Schenck, F. and von Weder, F. (1936). Uber das antirachitisch wirksame
bestralings-rodukt aus 7-dehydrocholesterin.lIoppe-Seylers Z Physiol, Chem. 241: 100-
103.
Weinstein, R.S., Underwood, J.L., Hutson, M.S. and DeLuca H.F. (1984). Bone
histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus.
Am. J. Physiol. 246: E499-E505.
180
Weiner, S., Noff, D., Meyer, M.S., Weisr.tan, Y. and Edelstein, S. (1979).
Metabolism of cholecalciferol in land snails. J. Biochem. 184: 157-161.
Yahav, S. and Buffenstein, R. (in press, 1993). Cholecalciferol supplementation alters
gut function and improves digestibility in an underground inhabitant, the naked mole
rat, Heterocephalus gZaber when fed a carrot diet. Brit. J. Nutr.
Zar, 1.J. (1974), Biostatistical Analysis. Prentice Hall Inc, London.
Zelikovic, I. and Chesney, R.W. (1989). yitamin D and mineral metabolism: The role
of the kidney ill health and disease. In: Impact of Nutrition on Health andDsease. (Ed,
Bourne, G.H.) World Rev. Nutr. Diet. Basel, Karger, volume 59, pp 156~216.
Zerwekh, J.E., Lindell, T.J. and Haussler, M.R. (1976). Increased intestinal chromatin
template activity: influence of 1,25-dihydroxyvitamin D3 and hormone-receptor
complexes, J. BioI. Chem. 251: 2:.188-2394.
Zofkova, I., Bednar, J., Nedvidkova, J. and Staika, L. (1991). Non-classical hormonal
actions of calcitriol. In: Vitamin D, Gene Regulation, Structure-Functi.on Analysis and
Clinical Application. (Eds. Norman, 'A.W., Bouillon, R., Thomasset, M.) Walter de
Gruyter, Berlin, pp 677-678.

·#1'1. i
Author: Cavaleros, M
Name of thesis: Vitamin d metabolism in the fruit bat ( Rousettus Aegyptiacus).
PUBLISHER:
University of the Witwatersrand, Johannesburg
©2015
LEGALNOTICES:
Copyright Notice: All materials on the Un ive rs ity of th e Witwa te rs ra nd, J0 han nesb u rg Li b ra ry website
are protected by South African copyright law and may not be distributed, transmitted, displayed or otherwise published
in any format, without the prior written permission of the copyright owner.
Disclaimer and Terms of Use: Provided that you maintain all copyright and other notices contained therein, you
may download material (one machine readable copy and one print copy per page)for your personal and/or
educational non-commercial use only.
The University of the Witwatersrand, Johannesburg, is not responsible for any errors or omissions and excludes any
and all liability for any errors in or omissions from the information on the Library website.
